Psyllid ID: psy6207
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 823 | ||||||
| 383848080 | 1002 | PREDICTED: multiple epidermal growth fac | 0.778 | 0.639 | 0.444 | 1e-160 | |
| 380024321 | 1001 | PREDICTED: multiple epidermal growth fac | 0.776 | 0.638 | 0.445 | 1e-160 | |
| 345495719 | 1020 | PREDICTED: multiple epidermal growth fac | 0.783 | 0.632 | 0.440 | 1e-159 | |
| 307193492 | 1007 | Multiple epidermal growth factor-like do | 0.778 | 0.636 | 0.437 | 1e-155 | |
| 380024323 | 990 | PREDICTED: multiple epidermal growth fac | 0.763 | 0.634 | 0.438 | 1e-154 | |
| 307182743 | 991 | Multiple epidermal growth factor-like do | 0.817 | 0.679 | 0.435 | 1e-154 | |
| 350424059 | 993 | PREDICTED: multiple epidermal growth fac | 0.818 | 0.678 | 0.433 | 1e-154 | |
| 332022203 | 962 | Multiple epidermal growth factor-like do | 0.765 | 0.654 | 0.435 | 1e-153 | |
| 189234402 | 993 | PREDICTED: similar to draper CG2086-PB [ | 0.778 | 0.645 | 0.439 | 1e-153 | |
| 340726359 | 991 | PREDICTED: multiple epidermal growth fac | 0.770 | 0.639 | 0.430 | 1e-153 |
| >gi|383848080|ref|XP_003699680.1| PREDICTED: multiple epidermal growth factor-like domains protein 11-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1477), Expect = e-160, Method: Compositional matrix adjust.
Identities = 310/698 (44%), Positives = 408/698 (58%), Gaps = 57/698 (8%)
Query: 126 KLCVPVCTDECIRGTCIAPNTCKCEVGFGGPTCNIECPEGHYGPDCKLACQCENGAGCDP 185
+ C+P+C+ +C+ GTCIAP+ CKCE G+GGP C+ +CP G +G C+ C C+N A CDP
Sbjct: 95 ERCIPICSKDCVHGTCIAPDVCKCESGYGGPLCDYKCPPGKWGKSCEKDCLCQNDASCDP 154
Query: 186 NTGACDCLDGYMGTHCEEVCGPGRFGQNCSQECQCRNGAECHPATGECSCQPGFTGSLCE 245
G C C G+ G +CE+ C P R+GQ+C +EC+CRNG CH +GEC C PG+TG LC+
Sbjct: 155 FDGKCRCTRGWTGDYCEQQCSPDRYGQDCGEECRCRNGGSCHHISGECHCAPGYTGPLCD 214
Query: 246 ERCPPGTHGPSCINRCRCQNGAICNPANGQCLCAPGWMGSVCNVPCTPGMWGQGCTVPCE 305
+ CPPG HG C + C+CQNG CNP G C CAPGW G VC + C G WG+ C+ C+
Sbjct: 215 DFCPPGKHGDECKSDCKCQNGGSCNPTTGSCYCAPGWTGIVCALRCPEGFWGKNCSQVCD 274
Query: 306 CFNGASCHHVTGECQCEPGFKGQKCMDPCPEGTWGKQCVHYCSCPVESMECSRIDGNCSC 365
C+N ASCHH+TGEC+C+PG+ KC+ CPEG +G C C+C +CS ++G C+C
Sbjct: 275 CYNKASCHHLTGECECKPGYYDVKCLQICPEGKFGLNCTSNCTCE-NGADCSPVNGTCTC 333
Query: 366 PPGFRGAKCKERTCPDGLYGEGCDRTCECNVENTKLCHAVTGKCECGPGWDGLTCDRPCP 425
PG+ G KC +R CPDGL+G C + C+C+ +NT LCH TG+C C GWDG TC+RPCP
Sbjct: 334 KPGWTGKKCNKRACPDGLFGPNCLKVCQCSDDNTDLCHPATGECICKAGWDGETCNRPCP 393
Query: 426 ITRWGDNCSQHCNCKNDALCFPRNGTNTYQYFFLQSLTLFTFLSLTHSGFSGRHCEKPCP 485
+G C CNCKN+A C P NGT + +G+ G C + CP
Sbjct: 394 FYTYGKGCQNRCNCKNNAQCLPINGT-----------------CICAAGYRGEDCSEVCP 436
Query: 486 QGSYGQDCSQTCLCSKEGSASCSPGSGQCVCRPGGAGQLCDRPCSEGRYGQNCTQECRCM 545
+YG++C+Q C+C + A+CSP +G+C C G G CDRPC + +G+NC +C+C
Sbjct: 437 DHTYGENCAQKCVC--KNGATCSPENGRCNCTAGWVGVSCDRPCDDRSFGRNCEGKCKCF 494
Query: 546 NGAACNPQDGTCLCPAGYYGPLCQKRCEFMTYGRNCAQACTCFTENSQGCDIVTGKCICR 605
N AACNPQ+GTC C AG+ G LCQ C+ +G C Q C C +NS GCD TG+CIC+
Sbjct: 495 NNAACNPQNGTCTCAAGFTGELCQDHCKTGYFGLGCTQVCDCHEDNSLGCDPATGRCICK 554
Query: 606 PGFKGHRCETQCSNPNTYGEDCSLDCGCNNGGTCNQLDGGCNCGRGYQGKLCTAPCPEGQ 665
P ++G RCET+C YG DC C C N +C+ G C C RG++G C+ PC EG
Sbjct: 555 PEWRGVRCETKCPE-GLYGNDCHSHCECMNNSSCDPDTGTCICARGWEGADCSQPCKEGW 613
Query: 666 YGYNCKEECLTKGQDVPVRTAVSHALKVHMGINARRYVNVRMVATFNTTLYLYLFVNLTY 725
YG CKE+C K QD V+ G ++ LT
Sbjct: 614 YGVGCKEKCPEKMQDNMTCDHVTGEYVCRPG-----------------------YLGLT- 649
Query: 726 GILYKTLVRLRECEERCPPGTHGPSCINRCRCQNGAICNPANGQCLCAPGWMGSVCNVPC 785
CE CPP +G +C NRCRC+NG C+ G C C PGW C PC
Sbjct: 650 ------------CEHPCPPNRYGLNCANRCRCKNGGECHHVTGICQCRPGWKDEHCQTPC 697
Query: 786 TPGMWGQGCTVPCECFNGASCHHVTGECQCEPGFKGQK 823
G +G C+ C C NG C G C+C PG+ G K
Sbjct: 698 PEGTYGINCSQHCTCQNGGKCRSNDGHCRCAPGWIGTK 735
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380024321|ref|XP_003695949.1| PREDICTED: multiple epidermal growth factor-like domains protein 10-like isoform 1 [Apis florea] | Back alignment and taxonomy information |
|---|
| >gi|345495719|ref|XP_001606322.2| PREDICTED: multiple epidermal growth factor-like domains protein 11-like [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
| >gi|307193492|gb|EFN76269.1| Multiple epidermal growth factor-like domains 10 [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
| >gi|380024323|ref|XP_003695950.1| PREDICTED: multiple epidermal growth factor-like domains protein 10-like isoform 2 [Apis florea] | Back alignment and taxonomy information |
|---|
| >gi|307182743|gb|EFN69867.1| Multiple epidermal growth factor-like domains 11 [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
| >gi|350424059|ref|XP_003493675.1| PREDICTED: multiple epidermal growth factor-like domains protein 10-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
| >gi|332022203|gb|EGI62518.1| Multiple epidermal growth factor-like domains 10 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
| >gi|189234402|ref|XP_974971.2| PREDICTED: similar to draper CG2086-PB [Tribolium castaneum] gi|270002777|gb|EEZ99224.1| draper [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
| >gi|340726359|ref|XP_003401527.1| PREDICTED: multiple epidermal growth factor-like domains protein 10-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 823 | ||||||
| UNIPROTKB|E1C393 | 1132 | MEGF10 "Uncharacterized protei | 0.778 | 0.566 | 0.380 | 2.8e-165 | |
| UNIPROTKB|F1PYQ7 | 1604 | MEGF6 "Uncharacterized protein | 0.783 | 0.402 | 0.374 | 1.4e-163 | |
| UNIPROTKB|F1PYQ8 | 1573 | MEGF6 "Uncharacterized protein | 0.783 | 0.410 | 0.374 | 1.4e-163 | |
| UNIPROTKB|F1NXF9 | 1371 | Gga.18391 "Uncharacterized pro | 0.952 | 0.571 | 0.336 | 2.9e-160 | |
| UNIPROTKB|A0JM12 | 1114 | megf10 "Multiple epidermal gro | 0.763 | 0.563 | 0.379 | 3.3e-158 | |
| WB|WBGene00013416 | 1714 | Y64G10A.7 [Caenorhabditis eleg | 0.771 | 0.370 | 0.371 | 5.4e-158 | |
| ZFIN|ZDB-GENE-090312-12 | 1513 | megf6a "multiple EGF-like-doma | 0.931 | 0.506 | 0.338 | 6.2e-157 | |
| UNIPROTKB|Q96KG7 | 1140 | MEGF10 "Multiple epidermal gro | 0.763 | 0.550 | 0.374 | 5.5e-156 | |
| ZFIN|ZDB-GENE-060503-252 | 1114 | megf11 "multiple EGF-like-doma | 0.713 | 0.526 | 0.380 | 3e-155 | |
| UNIPROTKB|F1MET4 | 1136 | MEGF10 "Uncharacterized protei | 0.763 | 0.552 | 0.371 | 8e-155 |
| UNIPROTKB|E1C393 MEGF10 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1356 (482.4 bits), Expect = 2.8e-165, Sum P(2) = 2.8e-165
Identities = 267/701 (38%), Positives = 348/701 (49%)
Query: 3 CVPVCTDECIRGTCIAPNTCKCEVGFGGPTCNIAKDAKT-KPTDTYTFRLMFPQCMDP-- 59
CVP C D+C+ G CIAPNTC+CE G+GGP C+ A D+ P + + +P
Sbjct: 105 CVPHCADKCVHGRCIAPNTCQCEPGWGGPNCSSACDSDHWGPHCSSRCQCKNGALCNPIT 164
Query: 60 ----CPEGTWGKQCVHYCSCPVESMECSRIDGNCSCPPGFRGAKCKERT----CPDGLYG 111
C G G +C C +C + C C GA C T CP G G
Sbjct: 165 GACHCASGFKGWRCEERCDQGTYGNDCHQ---KCQCQ---NGATCDHVTGECRCPPGYTG 218
Query: 112 EGCDRTCECNVENTKLCVPVCTDECI---RGTCI-APNTCKCEVGF--GGPTCNIECPEG 165
C+ C P C + C G C C C G+ G C CPEG
Sbjct: 219 AFCEDLCPPGKHG-----PQCEERCPCQNGGICHHVTGECACPPGWMTQGMVCGQPCPEG 273
Query: 166 HYGPDCKLACQCENGAGCDPNTGACDCLDGYMGTHCEEVCGPGRFGQNCSQECQCRNGAE 225
YG +C CQC NG CD TG C C GY G C++ C G +G C++ CQC NG +
Sbjct: 274 RYGNNCSQECQCHNGGICDSATGQCHCSPGYTGERCQDECPVGTYGVRCAETCQCMNGGK 333
Query: 226 CHPATGECSCQPGFTGSLCEER-CPPGTHGPSCINRCRCQ--NGAICNPANGQCLCAPGW 282
C+ +G C C+PG+TG CE R CP G +G C +C C N C+P +G+C C PGW
Sbjct: 334 CYHISGACLCEPGYTGEHCETRLCPEGVYGLKCDKKCPCHLHNTWSCHPMSGECSCKPGW 393
Query: 283 MGSVCNVPCTPGMWGQGCTVPCECFNGASCHHVTGECQCEPGFKGQKCMDPCPEGTWGKQ 342
G CN C+PG +G+ C C C NGA C VTG+C C GFKG C PC GT+G
Sbjct: 394 SGLYCNETCSPGFYGKSCQQICSCQNGADCDSVTGKCICASGFKGADCGTPCLPGTYGVN 453
Query: 343 CVHYCSCPVESMECSRIDGNCSCPPGFRGAKCKERTCPDGLYGEGCDRTCECNVENTKLC 402
C C+C E++ CS +DG+C+C G+ G C CP G +G GC+ TC+C N C
Sbjct: 454 CSSVCNCKNEAI-CSSVDGSCTCKAGWHGVDCSIN-CPSGTWGLGCNLTCQCL--NGGAC 509
Query: 403 HAVTGKCECGPGWDGLTCDRPCPITRWGDNCSQHCNCKNDALCFPRNGTNTYQYXXXXXX 462
+A+ G C C PGW G C+ PC +G +C++ C+C + C P G Y
Sbjct: 510 NALDGTCTCAPGWRGEKCELPCQDGTYGMDCAERCDCSHADGCHPTTG-----YCRCLPG 564
Query: 463 XXXXXXXXXXXXXXGRHCEKPCPQGSYGQDCSQTCLCSKEGSASCSPGSGQCVCRPGGAG 522
G HC+ C +G +G +CS +C C K G ASCSP G C C PG G
Sbjct: 565 WS------------GIHCDSVCAEGQWGPNCSLSCYC-KNG-ASCSPDDGICECAPGYRG 610
Query: 523 QLCDRPCSEGRYGQNCTQEC-RCMNGAA-CNPQDGTCLCPAGYYGPLCQKRCEFMTYGRN 580
C R CS G YG C+Q C +C++ + C+ G C C G+ G LC + C +G+N
Sbjct: 611 TTCQRICSPGFYGHRCSQTCPQCVHSSGPCHHITGLCDCLPGFTGALCNEVCPSGRFGKN 670
Query: 581 CAQACTCFTENSQGCDIVTGKCICRPGFKGHRCETQCSNPNTYGEDCSLDCGCNNGGTCN 640
C CTC T N C+ + C C PG+ G C C P+ +G +C C C+NG C+
Sbjct: 671 CIGICTC-TNNGT-CNPIDRSCQCYPGWIGSDCSQPCP-PSHWGPNCIHTCNCHNGAYCS 727
Query: 641 QLDGGCNCGRGYQGKLCTAPCPEGQYGYNCKEECLTK-GQD 680
DG C C G+ G CT CP G YG +C C + G D
Sbjct: 728 AYDGECKCTPGWTGLYCTQRCPLGFYGKDCALICQCRNGAD 768
|
|
| UNIPROTKB|F1PYQ7 MEGF6 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1PYQ8 MEGF6 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1NXF9 Gga.18391 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|A0JM12 megf10 "Multiple epidermal growth factor-like domains protein 10" [Xenopus (Silurana) tropicalis (taxid:8364)] | Back alignment and assigned GO terms |
|---|
| WB|WBGene00013416 Y64G10A.7 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
| ZFIN|ZDB-GENE-090312-12 megf6a "multiple EGF-like-domains 6a" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|Q96KG7 MEGF10 "Multiple epidermal growth factor-like domains protein 10" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
| ZFIN|ZDB-GENE-060503-252 megf11 "multiple EGF-like-domains 11" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1MET4 MEGF10 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Prediction of Enzyme Commission (EC) Number
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
No hit with e-value below 0.005
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 823 | |||
| KOG0994|consensus | 1758 | 100.0 | ||
| KOG0994|consensus | 1758 | 99.98 | ||
| KOG1836|consensus | 1705 | 99.77 | ||
| KOG1836|consensus | 1705 | 99.76 | ||
| KOG4289|consensus | 2531 | 99.7 | ||
| KOG4289|consensus | 2531 | 99.61 | ||
| KOG1225|consensus | 525 | 99.38 | ||
| KOG1225|consensus | 525 | 99.38 | ||
| KOG1217|consensus | 487 | 99.25 | ||
| KOG1217|consensus | 487 | 99.24 | ||
| KOG1219|consensus | 4289 | 98.96 | ||
| KOG1218|consensus | 316 | 98.95 | ||
| KOG1218|consensus | 316 | 98.94 | ||
| KOG1219|consensus | 4289 | 98.94 | ||
| KOG1214|consensus | 1289 | 98.69 | ||
| KOG1214|consensus | 1289 | 98.65 | ||
| KOG1226|consensus | 783 | 98.54 | ||
| KOG1226|consensus | 783 | 98.48 | ||
| KOG4260|consensus | 350 | 98.05 | ||
| KOG4260|consensus | 350 | 97.81 | ||
| KOG3512|consensus | 592 | 97.37 | ||
| smart00051 | 63 | DSL delta serrate ligand. | 96.82 | |
| KOG3512|consensus | 592 | 96.79 | ||
| PF00008 | 32 | EGF: EGF-like domain This is a sub-family of the P | 96.71 | |
| PF07974 | 32 | EGF_2: EGF-like domain; InterPro: IPR013111 A sequ | 96.27 | |
| PF07974 | 32 | EGF_2: EGF-like domain; InterPro: IPR013111 A sequ | 96.26 | |
| PF00008 | 32 | EGF: EGF-like domain This is a sub-family of the P | 96.25 | |
| smart00051 | 63 | DSL delta serrate ligand. | 96.23 | |
| cd00055 | 50 | EGF_Lam Laminin-type epidermal growth factor-like | 96.19 | |
| PF00053 | 49 | Laminin_EGF: Laminin EGF-like (Domains III and V); | 96.12 | |
| cd00055 | 50 | EGF_Lam Laminin-type epidermal growth factor-like | 95.76 | |
| smart00179 | 39 | EGF_CA Calcium-binding EGF-like domain. | 95.72 | |
| smart00180 | 46 | EGF_Lam Laminin-type epidermal growth factor-like | 95.48 | |
| PF00053 | 49 | Laminin_EGF: Laminin EGF-like (Domains III and V); | 95.31 | |
| smart00180 | 46 | EGF_Lam Laminin-type epidermal growth factor-like | 95.23 | |
| smart00179 | 39 | EGF_CA Calcium-binding EGF-like domain. | 94.91 | |
| cd00054 | 38 | EGF_CA Calcium-binding EGF-like domain, present in | 94.77 | |
| PF12661 | 13 | hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E | 94.55 | |
| PF12661 | 13 | hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E | 94.45 | |
| PF12947 | 36 | EGF_3: EGF domain; InterPro: IPR024731 This entry | 94.18 | |
| PF07645 | 42 | EGF_CA: Calcium-binding EGF domain; InterPro: IPR0 | 94.13 | |
| PF07645 | 42 | EGF_CA: Calcium-binding EGF domain; InterPro: IPR0 | 93.88 | |
| cd00054 | 38 | EGF_CA Calcium-binding EGF-like domain, present in | 93.54 | |
| cd00053 | 36 | EGF Epidermal growth factor domain, found in epide | 93.2 | |
| PF12947 | 36 | EGF_3: EGF domain; InterPro: IPR024731 This entry | 93.0 | |
| smart00181 | 35 | EGF Epidermal growth factor-like domain. | 91.79 | |
| smart00181 | 35 | EGF Epidermal growth factor-like domain. | 91.6 | |
| PF12662 | 24 | cEGF: Complement Clr-like EGF-like | 91.46 | |
| cd00053 | 36 | EGF Epidermal growth factor domain, found in epide | 91.3 | |
| PF12662 | 24 | cEGF: Complement Clr-like EGF-like | 88.77 | |
| PF06247 | 197 | Plasmod_Pvs28: Plasmodium ookinete surface protein | 85.49 | |
| PF01414 | 63 | DSL: Delta serrate ligand; InterPro: IPR001774 Lig | 84.41 |
| >KOG0994|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-31 Score=298.75 Aligned_cols=540 Identities=32% Similarity=0.858 Sum_probs=376.2
Q ss_pred CeeecCCCCcCCCCCCCCCCCCCCCCCc--ccccCCCcccCCCCCCCCCCCCCCCCCCCCCCCcccC----------C-C
Q psy6207 20 NTCKCEVGFGGPTCNIAKDAKTKPTDTY--TFRLMFPQCMDPCPEGTWGKQCVHYCSCPVESMECSR----------I-D 86 (823)
Q Consensus 20 ~~C~C~~G~~G~~C~~~~~~~~C~~~~~--~~~~~~~~C~~~C~~g~~G~~C~~~C~C~~~~~~C~~----------~-~ 86 (823)
..|.|.-.-.|.+|+...++-. .-++ ..+-....| ..|.|+.|+.+|+- + .
T Consensus 300 G~C~C~HNT~G~nCE~C~~fYn--DlPWrpAeG~~~neC--------------rkC~CNgHa~sCHFD~aV~~ASG~vSG 363 (1758)
T KOG0994|consen 300 GRCMCKHNTAGLNCEHCAPFYN--DLPWRPAEGKTSNEC--------------RKCECNGHADTCHFDMAVYEASGNVSG 363 (1758)
T ss_pred ceeEeccCCCCCChHHhhHhhc--CCCCCccCCCCcccc--------------cccCCCCCcccccccHHHHhhcCCccc
Confidence 5789999999999987432200 0011 001111122 13578888777751 1 2
Q ss_pred Cccc-CCCCccCCCCCccCCCCCCcCCCCC--------ccccccCCCCCcccccCCCCCCCccccC---------Cceee
Q psy6207 87 GNCS-CPPGFRGAKCKERTCPDGLYGEGCD--------RTCECNVENTKLCVPVCTDECIRGTCIA---------PNTCK 148 (823)
Q Consensus 87 ~~C~-C~~G~~G~~C~~~~C~~~~~g~~C~--------~~C~C~~~~~~~C~~~c~~~C~~G~C~~---------~~~C~ 148 (823)
|.|. |.+...|.+|+ .|.+.||-+.=. .+|.|.+.-. . ..|.|.. .+.|.
T Consensus 364 GVCDdCqHNT~G~~CE--~CkP~fYRdprr~i~~p~vC~pC~CdP~GS--------~--~~g~cds~~Dp~~GlvaGqC~ 431 (1758)
T KOG0994|consen 364 GVCDDCQHNTEGQNCE--RCKPFFYRDPRRDISDPDVCKPCECDPAGS--------Q--DGGICDSFCDPSTGLVAGQCR 431 (1758)
T ss_pred ccCccccccccccchh--hcCcccccCCCCCCCCccccccccCCCCcC--------c--CCCccccccCccccccccccc
Confidence 4775 99999999999 898887764210 2333322110 0 0134431 47899
Q ss_pred ccCCCCCCccccCCCCCCCCCCCCC-----CCCCC-----CCCeecCCCCcccCCCCCcCCCCCCCCCCCCCCCCCC---
Q psy6207 149 CEVGFGGPTCNIECPEGHYGPDCKL-----ACQCE-----NGAGCDPNTGACDCLDGYMGTHCEEVCGPGRFGQNCS--- 215 (823)
Q Consensus 149 C~~Gy~G~~C~~~c~~g~~g~~C~~-----~c~C~-----~~g~C~~~~g~C~C~~Gy~G~~C~~~C~~g~~g~~C~--- 215 (823)
|+++..|..|+ .|.+||||..-.. +|.|+ ++..|++.+|.|.|+.-.+|..|.. |.|.+||..=.
T Consensus 432 CK~~V~G~RCd-~Ck~Gywgl~~~dp~GC~~C~CN~lGT~~~s~CD~~TG~C~ckrlvTg~~cdq-clPeh~gLs~~~~g 509 (1758)
T KOG0994|consen 432 CKEHVAGRRCD-RCKDGYWGLTSADPYGCRPCDCNPLGTRNGSGCDPETGDCYCKRLVTGIDCDQ-CLPEHWGLSNDLEG 509 (1758)
T ss_pred cccCcCccccc-hhccCcccCccCCCCCccccccccccccCCCCCCCCCCceEeeccccCCCccc-cCccccccCCCCCC
Confidence 99999999999 5999999975333 24563 3445999999999999999999997 99999986433
Q ss_pred -CCCCCCCCC----eecCCCCccccCCCCCCCCCCcCCCCCC--------------------------------------
Q psy6207 216 -QECQCRNGA----ECHPATGECSCQPGFTGSLCEERCPPGT-------------------------------------- 252 (823)
Q Consensus 216 -~~~~C~~~g----~C~~~~~~C~C~~G~~G~~C~~~C~~g~-------------------------------------- 252 (823)
.++.|..+| +|...+++|.|+++|.|.+|+..++.-|
T Consensus 510 c~~cdcd~GGs~d~sc~~~sGqC~CRe~~~GR~c~~~~~~yy~~~l~h~i~eAe~~~~~~~~~v~~r~~~~~~~~~sftG 589 (1758)
T KOG0994|consen 510 CRPCDCDQGGSYDNSCDLHSGQCECREHMLGRRCEQVCPGYYSPVLDHYIYEAEDAGTGVEVNVKERKVLKSTKLPSFTG 589 (1758)
T ss_pred CcccccCCCCCCCcccccccCccccccccccccccccCCcccccccchhhhhhhhccccceeeeeeeeecccCCCccccc
Confidence 234676665 6777799999999999988876100000
Q ss_pred --------------------------------------------------------------------------------
Q psy6207 253 -------------------------------------------------------------------------------- 252 (823)
Q Consensus 253 -------------------------------------------------------------------------------- 252 (823)
T Consensus 590 ~gf~r~~e~~~l~f~~~~ip~sm~Ydv~ir~~~~~~~~wen~~itvqrp~~p~~g~c~~~~~~dd~~~~sl~p~sRyvv~ 669 (1758)
T KOG0994|consen 590 KGFVRVPEGTTLEFTVPIIPPSMEYDVLIRYDPRTPKLWENAKITVQRPGQPSLGRCGMAIPKDDRIPFSLPPGSRYVVA 669 (1758)
T ss_pred cceeecCCCceeeeecCCCCcccccchheeccCCCcchhhhheEEeecCCCCcccccccccccccccccccCCCceeeec
Confidence
Q ss_pred -----------------------------------------------CC-----------CCC---------------C-
Q psy6207 253 -----------------------------------------------HG-----------PSC---------------I- 258 (823)
Q Consensus 253 -----------------------------------------------~g-----------~~C---------------~- 258 (823)
.| -.| .
T Consensus 670 ~~~vClE~G~~Yklri~~~~~~~~~esp~aLiDSl~L~P~~~~l~iFqg~~~a~~~~yerYqC~~sl~~~k~~~~e~C~~ 749 (1758)
T KOG0994|consen 670 PNPVCLEAGKVYKLRIYFERKSHDVESPYALIDSLVLIPRIDVLPIFQGSVLADKKTYERYQCESSLSDMKTKSDEVCQN 749 (1758)
T ss_pred CCchhhccCcceEEEEEeccccCCcccchhhhhhhhhccccccccccccchhhhhHHHHHhhhhhcccccccCcchhhhh
Confidence 00 000 0
Q ss_pred -------------CCCCCCC----CCeecCCCCeeeCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCC----CCeecCC
Q psy6207 259 -------------NRCRCQN----GAICNPANGQCLCAPGWMGSVCNVPCTPGMWGQGCT--VPCECFN----GASCHHV 315 (823)
Q Consensus 259 -------------~~c~C~~----~g~C~~~~g~C~C~~G~~G~~C~~~C~~g~~g~~C~--~~~~C~~----~g~C~~~ 315 (823)
+.|.|.. .++|....|+|+|+|+..|+.|+ .|.+|+||..=+ ..+.|+. +.-|..+
T Consensus 750 l~~~lsa~l~n~a~~CnCnptGSlS~vCn~~GGqCqCkPnVVGR~Cd-qCApGtyGFGPsGCk~CdC~~~Gs~~~~Cd~~ 828 (1758)
T KOG0994|consen 750 LDNSLSALLHNGASMCNCNPTGSLSSVCNPNGGQCQCKPNVVGRRCD-QCAPGTYGFGPSGCKACDCNSIGSLDKYCDKI 828 (1758)
T ss_pred hhhhHHHHHhcCccccccCCCccccccccCCCceecccCcccccccc-ccCCcccCcCCccCcccccccccccccccccc
Confidence 0112222 23566566799999999999999 799999986422 3345654 3458889
Q ss_pred CCcccCCCCccCCCCCCCCCCCCCCCCCCCCCCCCCCCCeeecCCceEE-CCCCccCCCCCCccCCCCCCCCC-------
Q psy6207 316 TGECQCEPGFKGQKCMDPCPEGTWGKQCVHYCSCPVESMECSRIDGNCS-CPPGFRGAKCKERTCPDGLYGEG------- 387 (823)
Q Consensus 316 ~g~C~C~~G~~G~~C~~~C~~~~~g~~C~~~c~C~~~~g~C~~~~~~C~-C~~G~~G~~C~~~~C~~g~~g~~------- 387 (823)
+|+|+|.+|-.|..| +.|..|+||++--.+|.|+.+..+|+.+++.|+ |....+|..|+ .|.+||||++
T Consensus 829 tGQC~C~~g~ygrqC-nqCqpG~WgFPeCr~CqCNgHA~~Cd~~tGaCi~CqD~T~G~~Cd--rCl~GyyGdP~lg~g~~ 905 (1758)
T KOG0994|consen 829 TGQCQCRPGTYGRQC-NQCQPGYWGFPECRPCQCNGHADTCDPITGACIDCQDSTTGHSCD--RCLDGYYGDPRLGSGIG 905 (1758)
T ss_pred ccceeeccccchhhc-cccCCCccCCCcCccccccCcccccCccccccccccccccccchh--hhhccccCCcccCCCCC
Confidence 999999999999999 599999999987777888887678988899996 99999999998 8999999884
Q ss_pred CCCCCCCCCCC------CCcccC----CCcceEcCCCcccCCCCCCCCCCccCCCCCCC----CCCCCC------CcccC
Q psy6207 388 CDRTCECNVEN------TKLCHA----VTGKCECGPGWDGLTCDRPCPITRWGDNCSQH----CNCKND------ALCFP 447 (823)
Q Consensus 388 C~~~~~C~~~~------~~~C~~----~~~~C~C~~G~~G~~C~~~C~~~~~~~~C~~~----~~C~~~------g~C~~ 447 (823)
|. +++|..+. ...|.. ..-.|.|++||+|.+|+. |.+++||++-... +.|+++ +.|..
T Consensus 906 Cr-PCpCP~gp~Sg~~~A~sC~~d~~t~~ivC~C~~GY~G~RCe~-CA~~~fGnP~~GGtCq~CeC~~NiD~~d~~aCD~ 983 (1758)
T KOG0994|consen 906 CR-PCPCPDGPASGRQHADSCYLDTRTQQIVCHCQEGYSGSRCEI-CADNHFGNPSEGGTCQKCECSNNIDLYDPGACDV 983 (1758)
T ss_pred CC-CCCCCCCCccchhccccccccccccceeeecccCccccchhh-hcccccCCcccCCccccccccCCcCccCCCccch
Confidence 32 45666552 124442 123899999999999998 9999999875421 123332 23444
Q ss_pred CCCccccccccccccccceeeccCCCCccCCCCCCCCCCCCCCCCCCCC---cCCCCCC---CCcccCCCceeeCCCCCC
Q psy6207 448 RNGTNTYQYFFLQSLTLFTFLSLTHSGFSGRHCEKPCPQGSYGQDCSQT---CLCSKEG---SASCSPGSGQCVCRPGGA 521 (823)
Q Consensus 448 ~~g~C~~~~~~~~~~~~~s~~C~C~~Gy~G~~C~~~C~~g~~g~~C~~~---c~C~~~g---~g~C~~~~~~C~C~~G~~ 521 (823)
.+|.|. .|...-+|++|+. |.+||||+.=.+. +.|.-.| .+.|...+++|-|.|...
T Consensus 984 ~TG~CL----------------kCL~hTeG~hCe~-Ck~Gf~GdA~~q~CqrC~Cn~LGTn~~~~CDr~tGQCpClpNv~ 1046 (1758)
T KOG0994|consen 984 ATGACL----------------KCLYHTEGDHCEH-CKDGFYGDALRQNCQRCVCNFLGTNSTCHCDRFTGQCPCLPNVQ 1046 (1758)
T ss_pred hhchhh----------------hhhhcccccchhh-ccccchhHHHHhhhhhheccccccCCccccccccCcCCCCcccc
Confidence 444441 5777778999998 9999998875543 3354211 355667899999999999
Q ss_pred CCCCCCCCCCCcc----CCCCCCCCCCCC--CCeeeCCCcEEeCCCCCcCCCccccCcCCcCCCCCCC--CCCCCC--CC
Q psy6207 522 GQLCDRPCSEGRY----GQNCTQECRCMN--GAACNPQDGTCLCPAGYYGPLCQKRCEFMTYGRNCAQ--ACTCFT--EN 591 (823)
Q Consensus 522 G~~C~~~c~~g~~----~~~C~~~c~C~~--~g~C~~~~~~C~C~~G~~G~~C~~~c~~~~~g~~C~~--~~~C~~--~~ 591 (823)
|.+|+. |.+.+| |..|++- .|+. +-+|+..+++|.|.|||-|..|++ |.+-|+|++=.. .+.|+. ..
T Consensus 1047 G~~CDq-CA~N~w~laSG~GCe~C-~Cd~~~~pqCN~ftGQCqCkpGfGGR~C~q-Cqel~WGdP~~~C~aCdCd~rG~~ 1123 (1758)
T KOG0994|consen 1047 GVRCDQ-CAENHWNLASGEGCEPC-NCDPIGGPQCNEFTGQCQCKPGFGGRTCSQ-CQELYWGDPNEKCRACDCDPRGIE 1123 (1758)
T ss_pred cccccc-cccchhccccCCCCCcc-CCCccCCccccccccceeccCCCCCcchhH-HHHhhcCCCCCCceecCCCCCCCC
Confidence 999997 877766 4556642 4443 337888899999999999999984 888888886221 234421 12
Q ss_pred CCeeecCCCeEecCCCCCCCCccc
Q psy6207 592 SQGCDIVTGKCICRPGFKGHRCET 615 (823)
Q Consensus 592 ~~~C~~~~~~C~C~~G~~G~~C~~ 615 (823)
.-+|+..+++|+|.+|..|..|+.
T Consensus 1124 tpQCdr~tG~C~C~~Gv~G~rCdq 1147 (1758)
T KOG0994|consen 1124 TPQCDRATGRCVCRPGVGGPRCDQ 1147 (1758)
T ss_pred CCCccccCCceeecCCCCCcchhh
Confidence 346777889999999999998863
|
|
| >KOG0994|consensus | Back alignment and domain information |
|---|
| >KOG1836|consensus | Back alignment and domain information |
|---|
| >KOG1836|consensus | Back alignment and domain information |
|---|
| >KOG4289|consensus | Back alignment and domain information |
|---|
| >KOG4289|consensus | Back alignment and domain information |
|---|
| >KOG1225|consensus | Back alignment and domain information |
|---|
| >KOG1225|consensus | Back alignment and domain information |
|---|
| >KOG1217|consensus | Back alignment and domain information |
|---|
| >KOG1217|consensus | Back alignment and domain information |
|---|
| >KOG1219|consensus | Back alignment and domain information |
|---|
| >KOG1218|consensus | Back alignment and domain information |
|---|
| >KOG1218|consensus | Back alignment and domain information |
|---|
| >KOG1219|consensus | Back alignment and domain information |
|---|
| >KOG1214|consensus | Back alignment and domain information |
|---|
| >KOG1214|consensus | Back alignment and domain information |
|---|
| >KOG1226|consensus | Back alignment and domain information |
|---|
| >KOG1226|consensus | Back alignment and domain information |
|---|
| >KOG4260|consensus | Back alignment and domain information |
|---|
| >KOG4260|consensus | Back alignment and domain information |
|---|
| >KOG3512|consensus | Back alignment and domain information |
|---|
| >smart00051 DSL delta serrate ligand | Back alignment and domain information |
|---|
| >KOG3512|consensus | Back alignment and domain information |
|---|
| >PF00008 EGF: EGF-like domain This is a sub-family of the Pfam entry This is a sub-family of the Pfam entry; InterPro: IPR006209 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins | Back alignment and domain information |
|---|
| >PF07974 EGF_2: EGF-like domain; InterPro: IPR013111 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins | Back alignment and domain information |
|---|
| >PF07974 EGF_2: EGF-like domain; InterPro: IPR013111 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins | Back alignment and domain information |
|---|
| >PF00008 EGF: EGF-like domain This is a sub-family of the Pfam entry This is a sub-family of the Pfam entry; InterPro: IPR006209 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins | Back alignment and domain information |
|---|
| >smart00051 DSL delta serrate ligand | Back alignment and domain information |
|---|
| >cd00055 EGF_Lam Laminin-type epidermal growth factor-like domain; laminins are the major noncollagenous components of basement membranes that mediate cell adhesion, growth migration, and differentiation; the laminin-type epidermal growth factor-like module occurs in tandem arrays; the domain contains 4 disulfide bonds (loops a-d) the first three resemble epidermal growth factor (EGF); the number of copies of this domain in the different forms of laminins is highly variable ranging from 3 up to 22 copies | Back alignment and domain information |
|---|
| >PF00053 Laminin_EGF: Laminin EGF-like (Domains III and V); InterPro: IPR002049 Laminins [] are the major noncollagenous components of basement membranes that mediate cell adhesion, growth migration, and differentiation | Back alignment and domain information |
|---|
| >cd00055 EGF_Lam Laminin-type epidermal growth factor-like domain; laminins are the major noncollagenous components of basement membranes that mediate cell adhesion, growth migration, and differentiation; the laminin-type epidermal growth factor-like module occurs in tandem arrays; the domain contains 4 disulfide bonds (loops a-d) the first three resemble epidermal growth factor (EGF); the number of copies of this domain in the different forms of laminins is highly variable ranging from 3 up to 22 copies | Back alignment and domain information |
|---|
| >smart00179 EGF_CA Calcium-binding EGF-like domain | Back alignment and domain information |
|---|
| >smart00180 EGF_Lam Laminin-type epidermal growth factor-like domai | Back alignment and domain information |
|---|
| >PF00053 Laminin_EGF: Laminin EGF-like (Domains III and V); InterPro: IPR002049 Laminins [] are the major noncollagenous components of basement membranes that mediate cell adhesion, growth migration, and differentiation | Back alignment and domain information |
|---|
| >smart00180 EGF_Lam Laminin-type epidermal growth factor-like domai | Back alignment and domain information |
|---|
| >smart00179 EGF_CA Calcium-binding EGF-like domain | Back alignment and domain information |
|---|
| >cd00054 EGF_CA Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins | Back alignment and domain information |
|---|
| >PF12661 hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E26_A 3A7Q_A 2YGP_A 2YGO_A 1HRE_A 1HAE_A 1HAF_A 1HRF_A | Back alignment and domain information |
|---|
| >PF12661 hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E26_A 3A7Q_A 2YGP_A 2YGO_A 1HRE_A 1HAE_A 1HAF_A 1HRF_A | Back alignment and domain information |
|---|
| >PF12947 EGF_3: EGF domain; InterPro: IPR024731 This entry represents an EGF domain found in the the C terminus of malarial parasite merozoite surface protein 1 [], as well as other proteins | Back alignment and domain information |
|---|
| >PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins | Back alignment and domain information |
|---|
| >PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins | Back alignment and domain information |
|---|
| >cd00054 EGF_CA Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins | Back alignment and domain information |
|---|
| >cd00053 EGF Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium | Back alignment and domain information |
|---|
| >PF12947 EGF_3: EGF domain; InterPro: IPR024731 This entry represents an EGF domain found in the the C terminus of malarial parasite merozoite surface protein 1 [], as well as other proteins | Back alignment and domain information |
|---|
| >smart00181 EGF Epidermal growth factor-like domain | Back alignment and domain information |
|---|
| >smart00181 EGF Epidermal growth factor-like domain | Back alignment and domain information |
|---|
| >PF12662 cEGF: Complement Clr-like EGF-like | Back alignment and domain information |
|---|
| >cd00053 EGF Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium | Back alignment and domain information |
|---|
| >PF12662 cEGF: Complement Clr-like EGF-like | Back alignment and domain information |
|---|
| >PF06247 Plasmod_Pvs28: Plasmodium ookinete surface protein Pvs28; InterPro: IPR010423 This family consists of several ookinete surface protein (Pvs28) from several species of Plasmodium | Back alignment and domain information |
|---|
| >PF01414 DSL: Delta serrate ligand; InterPro: IPR001774 Ligands of the Delta/Serrate/lag-2 (DSL) family and their receptors, members of the lin-12/Notch family, mediate cell-cell interactions that specify cell fate in invertebrates and vertebrates | Back alignment and domain information |
|---|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 823 | ||||
| 2gy5_A | 423 | Tie2 Ligand-Binding Domain Crystal Structure Length | 9e-17 | ||
| 2gy5_A | 423 | Tie2 Ligand-Binding Domain Crystal Structure Length | 2e-15 | ||
| 2gy5_A | 423 | Tie2 Ligand-Binding Domain Crystal Structure Length | 5e-15 | ||
| 2gy5_A | 423 | Tie2 Ligand-Binding Domain Crystal Structure Length | 1e-07 | ||
| 2ygq_A | 324 | Wif Domain-Epidermal Growth Factor (Egf)-Like Domai | 8e-08 |
| >pdb|2GY5|A Chain A, Tie2 Ligand-Binding Domain Crystal Structure Length = 423 | Back alignment and structure |
|
| >pdb|2GY5|A Chain A, Tie2 Ligand-Binding Domain Crystal Structure Length = 423 | Back alignment and structure |
| >pdb|2GY5|A Chain A, Tie2 Ligand-Binding Domain Crystal Structure Length = 423 | Back alignment and structure |
| >pdb|2GY5|A Chain A, Tie2 Ligand-Binding Domain Crystal Structure Length = 423 | Back alignment and structure |
| >pdb|2YGQ|A Chain A, Wif Domain-Epidermal Growth Factor (Egf)-Like Domains 1-3 Of Human Wnt Inhibitory Factor 1 In Complex With 1,2-Dipalmitoylphosphatidylcholine Length = 324 | Back alignment and structure |
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 823 | |||
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 2e-29 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 6e-23 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 2e-21 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 7e-21 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 1e-19 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 8e-15 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 3e-13 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 5e-11 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 8e-10 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 3e-05 | |
| 3fcs_B | 690 | Integrin beta-3; beta propeller, rossmann fold, EG | 2e-25 | |
| 3fcs_B | 690 | Integrin beta-3; beta propeller, rossmann fold, EG | 8e-21 | |
| 3fcs_B | 690 | Integrin beta-3; beta propeller, rossmann fold, EG | 2e-17 | |
| 3fcs_B | 690 | Integrin beta-3; beta propeller, rossmann fold, EG | 3e-17 | |
| 3fcs_B | 690 | Integrin beta-3; beta propeller, rossmann fold, EG | 1e-15 | |
| 3fcs_B | 690 | Integrin beta-3; beta propeller, rossmann fold, EG | 6e-15 | |
| 3fcs_B | 690 | Integrin beta-3; beta propeller, rossmann fold, EG | 2e-14 | |
| 3fcs_B | 690 | Integrin beta-3; beta propeller, rossmann fold, EG | 2e-07 | |
| 3fcs_B | 690 | Integrin beta-3; beta propeller, rossmann fold, EG | 3e-06 | |
| 3fcs_B | 690 | Integrin beta-3; beta propeller, rossmann fold, EG | 3e-06 | |
| 4aqs_A | 525 | Laminin subunit beta-1; cell adhesion; HET: NAG BM | 3e-25 | |
| 4aqs_A | 525 | Laminin subunit beta-1; cell adhesion; HET: NAG BM | 2e-18 | |
| 4aqs_A | 525 | Laminin subunit beta-1; cell adhesion; HET: NAG BM | 4e-18 | |
| 4aqs_A | 525 | Laminin subunit beta-1; cell adhesion; HET: NAG BM | 1e-17 | |
| 4aqs_A | 525 | Laminin subunit beta-1; cell adhesion; HET: NAG BM | 8e-17 | |
| 4aqs_A | 525 | Laminin subunit beta-1; cell adhesion; HET: NAG BM | 8e-17 | |
| 4aqs_A | 525 | Laminin subunit beta-1; cell adhesion; HET: NAG BM | 9e-13 | |
| 4aqs_A | 525 | Laminin subunit beta-1; cell adhesion; HET: NAG BM | 9e-12 | |
| 4aqs_A | 525 | Laminin subunit beta-1; cell adhesion; HET: NAG BM | 4e-11 | |
| 4aqs_A | 525 | Laminin subunit beta-1; cell adhesion; HET: NAG BM | 2e-09 | |
| 3k6s_B | 687 | Integrin beta-2; cell receptor, adhesion molecule, | 2e-24 | |
| 3k6s_B | 687 | Integrin beta-2; cell receptor, adhesion molecule, | 4e-22 | |
| 3k6s_B | 687 | Integrin beta-2; cell receptor, adhesion molecule, | 1e-20 | |
| 3k6s_B | 687 | Integrin beta-2; cell receptor, adhesion molecule, | 3e-19 | |
| 3k6s_B | 687 | Integrin beta-2; cell receptor, adhesion molecule, | 3e-18 | |
| 3k6s_B | 687 | Integrin beta-2; cell receptor, adhesion molecule, | 4e-17 | |
| 3k6s_B | 687 | Integrin beta-2; cell receptor, adhesion molecule, | 2e-14 | |
| 3k6s_B | 687 | Integrin beta-2; cell receptor, adhesion molecule, | 4e-11 | |
| 3k6s_B | 687 | Integrin beta-2; cell receptor, adhesion molecule, | 2e-09 | |
| 3k6s_B | 687 | Integrin beta-2; cell receptor, adhesion molecule, | 2e-05 | |
| 3k6s_B | 687 | Integrin beta-2; cell receptor, adhesion molecule, | 1e-04 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 9e-17 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 2e-15 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 9e-09 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 2e-07 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 7e-07 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 2e-06 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 3e-05 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 8e-05 | |
| 2vj2_A | 169 | Jagged-1; signalling, polymorphism, glycoprotein, | 1e-10 | |
| 2vj2_A | 169 | Jagged-1; signalling, polymorphism, glycoprotein, | 5e-07 | |
| 2vj2_A | 169 | Jagged-1; signalling, polymorphism, glycoprotein, | 2e-06 | |
| 2vj2_A | 169 | Jagged-1; signalling, polymorphism, glycoprotein, | 5e-06 | |
| 3zyj_B | 426 | Netrin-G1; cell adhesion, synapse; HET: NAG BMA MA | 5e-09 | |
| 3zyj_B | 426 | Netrin-G1; cell adhesion, synapse; HET: NAG BMA MA | 1e-05 | |
| 3zyj_B | 426 | Netrin-G1; cell adhesion, synapse; HET: NAG BMA MA | 2e-04 | |
| 4d90_A | 143 | EGF-like repeat and discoidin I-like domain-conta | 2e-07 | |
| 4d90_A | 143 | EGF-like repeat and discoidin I-like domain-conta | 4e-06 | |
| 4d90_A | 143 | EGF-like repeat and discoidin I-like domain-conta | 7e-06 | |
| 2dtg_E | 897 | Insulin receptor; IR ectodomain, X-RAY crystallogr | 2e-07 | |
| 1klo_A | 162 | Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: | 7e-07 | |
| 1klo_A | 162 | Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: | 6e-06 | |
| 2vj3_A | 135 | Neurogenic locus notch homolog protein 1; transcri | 2e-06 | |
| 2vj3_A | 135 | Neurogenic locus notch homolog protein 1; transcri | 1e-04 | |
| 1igr_A | 478 | Insulin-like growth factor receptor 1; hormone rec | 8e-06 | |
| 1igr_A | 478 | Insulin-like growth factor receptor 1; hormone rec | 8e-05 | |
| 1zlg_A | 680 | Anosmin 1; insulin-like growth factor receptor Cys | 9e-06 | |
| 1zlg_A | 680 | Anosmin 1; insulin-like growth factor receptor Cys | 2e-05 | |
| 1zlg_A | 680 | Anosmin 1; insulin-like growth factor receptor Cys | 1e-04 | |
| 1zlg_A | 680 | Anosmin 1; insulin-like growth factor receptor Cys | 5e-04 | |
| 1zlg_A | 680 | Anosmin 1; insulin-like growth factor receptor Cys | 7e-04 | |
| 2wg3_C | 463 | Hedgehog-interacting protein; lipoprotein, develop | 3e-05 | |
| 2wg3_C | 463 | Hedgehog-interacting protein; lipoprotein, develop | 5e-04 | |
| 2wg3_C | 463 | Hedgehog-interacting protein; lipoprotein, develop | 6e-04 | |
| 2hr7_A | 486 | Insulin receptor; hormone receptor, leucine rich r | 5e-05 | |
| 2hr7_A | 486 | Insulin receptor; hormone receptor, leucine rich r | 3e-04 | |
| 2hr7_A | 486 | Insulin receptor; hormone receptor, leucine rich r | 4e-04 | |
| 1x7a_L | 146 | Coagulation factor IX, light chain; inhibition, bl | 1e-04 | |
| 1x7a_L | 146 | Coagulation factor IX, light chain; inhibition, bl | 5e-04 | |
| 2vh0_B | 134 | Activated factor XA light chain; serine protease, | 2e-04 | |
| 2vh0_B | 134 | Activated factor XA light chain; serine protease, | 5e-04 | |
| 1mox_A | 501 | Epidermal growth factor receptor; EGFR, receptor, | 2e-04 | |
| 2uvo_A | 171 | Agglutinin isolectin 1; carbohydrate-binding prote | 2e-04 | |
| 1nfu_B | 195 | Coagulation factor XA, light chain; hydrolase; HET | 5e-04 | |
| 3h5c_B | 317 | Vitamin K-dependent protein Z; protein Z-protein Z | 7e-04 |
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Length = 423 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-29
Identities = 64/241 (26%), Positives = 91/241 (37%), Gaps = 8/241 (3%)
Query: 104 TCPDGLYGEGCDRTCECNVENTKLCVPVCTDECIRGTCIAPNTCKCEVGFGGPTCNIECP 163
+G + R ++ L D + C
Sbjct: 133 IYKNGSFIHSVPRHEVPDILEVHLPHAQPQDAGVYSAR--YIGGNLFTSAFTRLIVRRCE 190
Query: 164 EGHYGPDCKLACQ-CENGAGCDPNTGACDCLDGYMGTHCEEVCGPGRFGQNCSQECQ--- 219
+GP+C C C N C +TG C C G+MG CE+ C FG+ C + C
Sbjct: 191 AQKWGPECNHLCTACMNNGVCHEDTGECICPPGFMGRTCEKACELHTFGRTCKERCSGQE 250
Query: 220 -CRNGAECHPATGECSCQPGFTGSLCEERCPPGTHGPSCINRCRCQNGAICNPANGQCLC 278
C++ C P CSC G+ G C E C PG +GP C RC C NG +C+ G CLC
Sbjct: 251 GCKSYVFCLPDPYGCSCATGWKGLQCNEACHPGFYGPDCKLRCSCNNGEMCDRFQG-CLC 309
Query: 279 APGWMGSVCNVPCTPGMWGQGCTVPCECFNGASCHHVTGECQCEPGFKGQKCMDPCPEGT 338
+PGW G C P M + +P + + + P ++ P+GT
Sbjct: 310 SPGWQGLQCEREGIPRMTPKIVDLPDHIEVNSGKFNPICKASGWPLPTNEEMTLVKPDGT 369
Query: 339 W 339
Sbjct: 370 V 370
|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Length = 423 | Back alignment and structure |
|---|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Length = 423 | Back alignment and structure |
|---|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Length = 423 | Back alignment and structure |
|---|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Length = 423 | Back alignment and structure |
|---|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Length = 423 | Back alignment and structure |
|---|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Length = 423 | Back alignment and structure |
|---|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Length = 423 | Back alignment and structure |
|---|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Length = 423 | Back alignment and structure |
|---|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Length = 423 | Back alignment and structure |
|---|
| >3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 3ije_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* Length = 690 | Back alignment and structure |
|---|
| >3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 3ije_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* Length = 690 | Back alignment and structure |
|---|
| >3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 3ije_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* Length = 690 | Back alignment and structure |
|---|
| >3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 3ije_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* Length = 690 | Back alignment and structure |
|---|
| >3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 3ije_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* Length = 690 | Back alignment and structure |
|---|
| >3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 3ije_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* Length = 690 | Back alignment and structure |
|---|
| >3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 3ije_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* Length = 690 | Back alignment and structure |
|---|
| >3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 3ije_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* Length = 690 | Back alignment and structure |
|---|
| >3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 3ije_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* Length = 690 | Back alignment and structure |
|---|
| >3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 3ije_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* Length = 690 | Back alignment and structure |
|---|
| >4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} Length = 525 | Back alignment and structure |
|---|
| >4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} Length = 525 | Back alignment and structure |
|---|
| >4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} Length = 525 | Back alignment and structure |
|---|
| >4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} Length = 525 | Back alignment and structure |
|---|
| >4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} Length = 525 | Back alignment and structure |
|---|
| >4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} Length = 525 | Back alignment and structure |
|---|
| >4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} Length = 525 | Back alignment and structure |
|---|
| >4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} Length = 525 | Back alignment and structure |
|---|
| >4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} Length = 525 | Back alignment and structure |
|---|
| >4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} Length = 525 | Back alignment and structure |
|---|
| >3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687 | Back alignment and structure |
|---|
| >3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687 | Back alignment and structure |
|---|
| >3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687 | Back alignment and structure |
|---|
| >3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687 | Back alignment and structure |
|---|
| >3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687 | Back alignment and structure |
|---|
| >3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687 | Back alignment and structure |
|---|
| >3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687 | Back alignment and structure |
|---|
| >3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687 | Back alignment and structure |
|---|
| >3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687 | Back alignment and structure |
|---|
| >3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687 | Back alignment and structure |
|---|
| >3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687 | Back alignment and structure |
|---|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
| >2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A Length = 169 | Back alignment and structure |
|---|
| >2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A Length = 169 | Back alignment and structure |
|---|
| >2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A Length = 169 | Back alignment and structure |
|---|
| >2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A Length = 169 | Back alignment and structure |
|---|
| >3zyj_B Netrin-G1; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 426 | Back alignment and structure |
|---|
| >3zyj_B Netrin-G1; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 426 | Back alignment and structure |
|---|
| >3zyj_B Netrin-G1; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 426 | Back alignment and structure |
|---|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Length = 143 | Back alignment and structure |
|---|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Length = 143 | Back alignment and structure |
|---|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Length = 143 | Back alignment and structure |
|---|
| >2dtg_E Insulin receptor; IR ectodomain, X-RAY crystallography, hormone receptor/immune system complex; 3.80A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 c.10.2.5 c.10.2.5 g.3.9.1 PDB: 3loh_E Length = 897 | Back alignment and structure |
|---|
| >1klo_A Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: g.3.11.2 g.3.11.2 g.3.11.2 PDB: 1npe_B 1tle_A Length = 162 | Back alignment and structure |
|---|
| >1klo_A Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: g.3.11.2 g.3.11.2 g.3.11.2 PDB: 1npe_B 1tle_A Length = 162 | Back alignment and structure |
|---|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* Length = 135 | Back alignment and structure |
|---|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* Length = 135 | Back alignment and structure |
|---|
| >1igr_A Insulin-like growth factor receptor 1; hormone receptor, insulin receptor family; HET: NAG FUC BMA MAN; 2.60A {Homo sapiens} SCOP: c.10.2.5 c.10.2.5 g.3.9.1 Length = 478 | Back alignment and structure |
|---|
| >1igr_A Insulin-like growth factor receptor 1; hormone receptor, insulin receptor family; HET: NAG FUC BMA MAN; 2.60A {Homo sapiens} SCOP: c.10.2.5 c.10.2.5 g.3.9.1 Length = 478 | Back alignment and structure |
|---|
| >1zlg_A Anosmin 1; insulin-like growth factor receptor Cys-rich fold, WHEY acidic protein fold, fibronectin type III fold, hormone- growth factor complex; NMR {Homo sapiens} Length = 680 | Back alignment and structure |
|---|
| >1zlg_A Anosmin 1; insulin-like growth factor receptor Cys-rich fold, WHEY acidic protein fold, fibronectin type III fold, hormone- growth factor complex; NMR {Homo sapiens} Length = 680 | Back alignment and structure |
|---|
| >1zlg_A Anosmin 1; insulin-like growth factor receptor Cys-rich fold, WHEY acidic protein fold, fibronectin type III fold, hormone- growth factor complex; NMR {Homo sapiens} Length = 680 | Back alignment and structure |
|---|
| >1zlg_A Anosmin 1; insulin-like growth factor receptor Cys-rich fold, WHEY acidic protein fold, fibronectin type III fold, hormone- growth factor complex; NMR {Homo sapiens} Length = 680 | Back alignment and structure |
|---|
| >1zlg_A Anosmin 1; insulin-like growth factor receptor Cys-rich fold, WHEY acidic protein fold, fibronectin type III fold, hormone- growth factor complex; NMR {Homo sapiens} Length = 680 | Back alignment and structure |
|---|
| >2wg3_C Hedgehog-interacting protein; lipoprotein, development, membrane, secreted, protease, PALM hydrolase, developmental protein, autocatalytic cleavage; HET: NAG; 2.60A {Homo sapiens} PDB: 2wg4_B 2wfx_B 2wft_A 3ho3_A 3ho4_A 3ho5_A Length = 463 | Back alignment and structure |
|---|
| >2wg3_C Hedgehog-interacting protein; lipoprotein, development, membrane, secreted, protease, PALM hydrolase, developmental protein, autocatalytic cleavage; HET: NAG; 2.60A {Homo sapiens} PDB: 2wg4_B 2wfx_B 2wft_A 3ho3_A 3ho4_A 3ho5_A Length = 463 | Back alignment and structure |
|---|
| >2wg3_C Hedgehog-interacting protein; lipoprotein, development, membrane, secreted, protease, PALM hydrolase, developmental protein, autocatalytic cleavage; HET: NAG; 2.60A {Homo sapiens} PDB: 2wg4_B 2wfx_B 2wft_A 3ho3_A 3ho4_A 3ho5_A Length = 463 | Back alignment and structure |
|---|
| >2hr7_A Insulin receptor; hormone receptor, leucine rich repeat, transferase; HET: NAG BMA MAN FUC P33; 2.32A {Homo sapiens} Length = 486 | Back alignment and structure |
|---|
| >2hr7_A Insulin receptor; hormone receptor, leucine rich repeat, transferase; HET: NAG BMA MAN FUC P33; 2.32A {Homo sapiens} Length = 486 | Back alignment and structure |
|---|
| >2hr7_A Insulin receptor; hormone receptor, leucine rich repeat, transferase; HET: NAG BMA MAN FUC P33; 2.32A {Homo sapiens} Length = 486 | Back alignment and structure |
|---|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* Length = 146 | Back alignment and structure |
|---|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* Length = 146 | Back alignment and structure |
|---|
| >2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... Length = 134 | Back alignment and structure |
|---|
| >2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... Length = 134 | Back alignment and structure |
|---|
| >1mox_A Epidermal growth factor receptor; EGFR, receptor, complex, transferase-growth F complex; HET: NAG FUC BMA MAN; 2.50A {Homo sapiens} SCOP: c.10.2.5 c.10.2.5 g.3.9.1 g.3.9.1 Length = 501 | Back alignment and structure |
|---|
| >2uvo_A Agglutinin isolectin 1; carbohydrate-binding protein, hevein domain, chitin-binding, GERM agglutinin, chitin-binding protein; HET: NDG NAG GOL; 1.40A {Triticum aestivum} PDB: 1wgc_A* 2cwg_A* 2uwg_A* 2x3t_A* 4aml_A* 7wga_A 9wga_A 2wgc_A 1wgt_A 1k7t_A* 1k7v_A* 1k7u_A 2uwz_A* 2x52_A* 1t0w_A* Length = 171 | Back alignment and structure |
|---|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Length = 195 | Back alignment and structure |
|---|
| >3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 823 | |||
| 4fbr_A | 267 | Lectin, myxobacterial hemagglutinin; beta-barrel, | 99.78 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 99.77 | |
| 4fbr_A | 267 | Lectin, myxobacterial hemagglutinin; beta-barrel, | 99.76 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 99.75 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 99.73 | |
| 2vj2_A | 169 | Jagged-1; signalling, polymorphism, glycoprotein, | 99.72 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 99.71 | |
| 2vj2_A | 169 | Jagged-1; signalling, polymorphism, glycoprotein, | 99.68 | |
| 3fcs_B | 690 | Integrin beta-3; beta propeller, rossmann fold, EG | 99.58 | |
| 1klo_A | 162 | Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: | 99.54 | |
| 2vj3_A | 135 | Neurogenic locus notch homolog protein 1; transcri | 99.54 | |
| 3fcs_B | 690 | Integrin beta-3; beta propeller, rossmann fold, EG | 99.52 | |
| 2vj3_A | 135 | Neurogenic locus notch homolog protein 1; transcri | 99.51 | |
| 4aqs_A | 525 | Laminin subunit beta-1; cell adhesion; HET: NAG BM | 99.5 | |
| 1z1y_A | 186 | Ookinete surface protein PVS25; four EGF-like doma | 99.5 | |
| 4d90_A | 143 | EGF-like repeat and discoidin I-like domain-conta | 99.49 | |
| 1klo_A | 162 | Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: | 99.49 | |
| 1z1y_A | 186 | Ookinete surface protein PVS25; four EGF-like doma | 99.46 | |
| 4d90_A | 143 | EGF-like repeat and discoidin I-like domain-conta | 99.44 | |
| 4aqs_A | 525 | Laminin subunit beta-1; cell adhesion; HET: NAG BM | 99.42 | |
| 3k6s_B | 687 | Integrin beta-2; cell receptor, adhesion molecule, | 99.38 | |
| 3k6s_B | 687 | Integrin beta-2; cell receptor, adhesion molecule, | 99.32 | |
| 2bou_A | 143 | EGF-like module containing mucin-like hormone rece | 99.15 | |
| 2bou_A | 143 | EGF-like module containing mucin-like hormone rece | 99.14 | |
| 1tpg_A | 91 | T-plasminogen activator F1-G; plasminogen activati | 99.09 | |
| 1uzk_A | 162 | Fibrillin-1; glycoprotein, extra-cellular matrix, | 98.96 | |
| 1yo8_A | 634 | Thrombospondin-2; EGF, Ca(2+)-binding domains, lec | 98.93 | |
| 1tpg_A | 91 | T-plasminogen activator F1-G; plasminogen activati | 98.92 | |
| 1yo8_A | 634 | Thrombospondin-2; EGF, Ca(2+)-binding domains, lec | 98.92 | |
| 1dx5_I | 118 | Thrombomodulin; serine proteinase, EGF-like domain | 98.83 | |
| 1dx5_I | 118 | Thrombomodulin; serine proteinase, EGF-like domain | 98.77 | |
| 1n7d_A | 699 | LDL receptor, low-density lipoprotein receptor; fa | 98.77 | |
| 2w86_A | 147 | Fibrillin-1, fibrillin1; phosphoprotein, EGF-like | 98.71 | |
| 1uzk_A | 162 | Fibrillin-1; glycoprotein, extra-cellular matrix, | 98.65 | |
| 2p28_B | 217 | Integrin beta-2; hybrid domain, PSI domain, I-EGF | 98.63 | |
| 1n7d_A | 699 | LDL receptor, low-density lipoprotein receptor; fa | 98.59 | |
| 2w86_A | 147 | Fibrillin-1, fibrillin1; phosphoprotein, EGF-like | 98.59 | |
| 2p28_B | 217 | Integrin beta-2; hybrid domain, PSI domain, I-EGF | 98.56 | |
| 1aut_L | 114 | Activated protein C; serine proteinase, plasma cal | 98.4 | |
| 1aut_L | 114 | Activated protein C; serine proteinase, plasma cal | 98.33 | |
| 1emn_A | 82 | Fibrillin; extracellular matrix, calcium-binding, | 98.29 | |
| 3zyj_B | 426 | Netrin-G1; cell adhesion, synapse; HET: NAG BMA MA | 98.25 | |
| 1emn_A | 82 | Fibrillin; extracellular matrix, calcium-binding, | 98.25 | |
| 1x7a_L | 146 | Coagulation factor IX, light chain; inhibition, bl | 98.17 | |
| 3zyj_B | 426 | Netrin-G1; cell adhesion, synapse; HET: NAG BMA MA | 98.11 | |
| 2c4f_L | 142 | Coagulation factor VII precursor; blood coagulatio | 98.07 | |
| 1x7a_L | 146 | Coagulation factor IX, light chain; inhibition, bl | 98.07 | |
| 1nfu_B | 195 | Coagulation factor XA, light chain; hydrolase; HET | 98.04 | |
| 2wg3_C | 463 | Hedgehog-interacting protein; lipoprotein, develop | 98.02 | |
| 2c4f_L | 142 | Coagulation factor VII precursor; blood coagulatio | 98.0 | |
| 3u7u_G | 55 | Neuregulin 1; signaling protein, transferase-trans | 97.99 | |
| 2vh0_B | 134 | Activated factor XA light chain; serine protease, | 97.97 | |
| 3u7u_G | 55 | Neuregulin 1; signaling protein, transferase-trans | 97.97 | |
| 1z6c_A | 87 | Vitamin K-dependent protein S; EGF module, blood c | 97.91 | |
| 1lmj_A | 86 | Fibrillin 1; EGF, calcium, microfibril, neonatal, | 97.9 | |
| 1nfu_B | 195 | Coagulation factor XA, light chain; hydrolase; HET | 97.87 | |
| 3m0c_C | 791 | LDL receptor, low-density lipoprotein receptor; pr | 97.84 | |
| 3m0c_C | 791 | LDL receptor, low-density lipoprotein receptor; pr | 97.83 | |
| 1z6c_A | 87 | Vitamin K-dependent protein S; EGF module, blood c | 97.82 | |
| 2w2n_E | 107 | LDL receptor, low-density lipoprotein receptor; hy | 97.81 | |
| 1lmj_A | 86 | Fibrillin 1; EGF, calcium, microfibril, neonatal, | 97.77 | |
| 3h5c_B | 317 | Vitamin K-dependent protein Z; protein Z-protein Z | 97.75 | |
| 2vh0_B | 134 | Activated factor XA light chain; serine protease, | 97.75 | |
| 2wg3_C | 463 | Hedgehog-interacting protein; lipoprotein, develop | 97.71 | |
| 2w2n_E | 107 | LDL receptor, low-density lipoprotein receptor; hy | 97.7 | |
| 2y38_A | 403 | Laminin subunit alpha-5; structural protein, cell | 97.59 | |
| 3h5c_B | 317 | Vitamin K-dependent protein Z; protein Z-protein Z | 97.58 | |
| 2y38_A | 403 | Laminin subunit alpha-5; structural protein, cell | 97.49 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 97.48 | |
| 4aqt_A | 375 | Laminin subunit gamma-1; cell adhesion; HET: NAG B | 97.47 | |
| 4aqt_A | 375 | Laminin subunit gamma-1; cell adhesion; HET: NAG B | 97.45 | |
| 3ca7_A | 52 | Protein spitz; argos, EGF, developmental protein, | 97.22 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 97.19 | |
| 1egf_A | 53 | Epidermal growth factor; NMR {Mus musculus} SCOP: | 96.98 | |
| 1hae_A | 63 | Heregulin-alpha; growth factor; NMR {Homo sapiens} | 96.95 | |
| 3p5b_L | 400 | Low density lipoprotein receptor variant; B-propel | 96.8 | |
| 1k36_A | 46 | Epiregulin; EGF-like fold, hormone/growth factor c | 96.74 | |
| 2k2s_B | 61 | Micronemal protein 6; microneme protein complex, c | 96.53 | |
| 3p5b_L | 400 | Low density lipoprotein receptor variant; B-propel | 96.53 | |
| 2k2s_B | 61 | Micronemal protein 6; microneme protein complex, c | 96.47 | |
| 1a3p_A | 45 | Epidermal growth factor; disulfide connectivities, | 96.47 | |
| 1egf_A | 53 | Epidermal growth factor; NMR {Mus musculus} SCOP: | 96.34 | |
| 1a3p_A | 45 | Epidermal growth factor; disulfide connectivities, | 96.31 | |
| 1k36_A | 46 | Epiregulin; EGF-like fold, hormone/growth factor c | 96.03 | |
| 3v65_B | 386 | Low-density lipoprotein receptor-related protein; | 95.99 | |
| 1nql_B | 53 | Epidermal growth factor; cell surface receptor, ty | 95.9 | |
| 1hae_A | 63 | Heregulin-alpha; growth factor; NMR {Homo sapiens} | 95.81 | |
| 1nql_B | 53 | Epidermal growth factor; cell surface receptor, ty | 95.8 | |
| 2fd6_A | 122 | Urokinase-type plasminogen activator; UPAR, ATF, A | 95.77 | |
| 3ltf_D | 58 | Protein spitz; receptor-ligand complex ectodomain | 95.46 | |
| 3v65_B | 386 | Low-density lipoprotein receptor-related protein; | 95.44 | |
| 3ca7_A | 52 | Protein spitz; argos, EGF, developmental protein, | 94.83 | |
| 3ltf_D | 58 | Protein spitz; receptor-ligand complex ectodomain | 94.69 | |
| 2fd6_A | 122 | Urokinase-type plasminogen activator; UPAR, ATF, A | 94.68 | |
| 2ygo_A | 188 | WIF-1, WNT inhibitory factor 1; signaling protein, | 94.08 | |
| 3e50_C | 50 | Protransforming growth factor alpha; IDE, TGF-alph | 92.78 | |
| 2rnl_A | 50 | Amphiregulin; AR, colorectum cell-derived growth f | 92.18 | |
| 1g1s_A | 162 | P-selectin; selectin, lectin, EGF, sulphated, SLEX | 91.82 | |
| 2ygo_A | 188 | WIF-1, WNT inhibitory factor 1; signaling protein, | 91.54 | |
| 1xdt_R | 79 | Hbegf, heparin-binding epidermal growth factor; co | 90.98 | |
| 2i9a_A | 145 | Urokinase-type plasminogen activator; growth facto | 90.89 | |
| 2rnl_A | 50 | Amphiregulin; AR, colorectum cell-derived growth f | 90.86 | |
| 1iox_A | 50 | Betacellulin; EGF-like fold, hormone/growth factor | 90.81 | |
| 3e50_C | 50 | Protransforming growth factor alpha; IDE, TGF-alph | 90.59 | |
| 1g1s_A | 162 | P-selectin; selectin, lectin, EGF, sulphated, SLEX | 90.44 | |
| 2jkh_L | 55 | Factor X light chain; plasma, calcium, zymogen, se | 89.57 | |
| 2i9a_A | 145 | Urokinase-type plasminogen activator; growth facto | 89.09 | |
| 3nt1_A | 587 | Prostaglandin-endoperoxide synthase 2; prostagland | 88.97 | |
| 1q4g_A | 553 | Prostaglandin G/H synthase 1; cyclooxygenase, non- | 88.39 | |
| 1xdt_R | 79 | Hbegf, heparin-binding epidermal growth factor; co | 88.0 | |
| 3nt1_A | 587 | Prostaglandin-endoperoxide synthase 2; prostagland | 87.98 | |
| 1kig_L | 51 | Factor XA; glycoprotein, serine protease, plasma, | 87.7 | |
| 2bz6_L | 53 | Blood coagulation factor VIIA; serine protease, en | 87.27 | |
| 2p26_A | 280 | Integrin beta-2; hybrid domain, PSI domain, I-EGF | 85.89 | |
| 2p26_A | 280 | Integrin beta-2; hybrid domain, PSI domain, I-EGF | 85.8 | |
| 1ob1_C | 99 | Major merozoite surface protein; immune system, im | 85.67 | |
| 1apq_A | 53 | Complement protease C1R; EGF, calcium binding, ser | 85.3 | |
| 1ob1_C | 99 | Major merozoite surface protein; immune system, im | 85.28 | |
| 1n1i_A | 105 | Merozoite surface protein-1; MSP1, malaria, surfac | 84.83 | |
| 2e26_A | 725 | Reelin, reeler protein; signaling protein; HET: NA | 84.4 | |
| 1n1i_A | 105 | Merozoite surface protein-1; MSP1, malaria, surfac | 83.92 | |
| 1apq_A | 53 | Complement protease C1R; EGF, calcium binding, ser | 83.36 | |
| 1iox_A | 50 | Betacellulin; EGF-like fold, hormone/growth factor | 82.49 | |
| 2e26_A | 725 | Reelin, reeler protein; signaling protein; HET: NA | 81.56 | |
| 2kl7_A | 71 | Fibulin-4; secreted, calcium, disease mutation, di | 81.25 | |
| 1gl4_A | 285 | Nidogen-1, entactin; immunoglobulin-like domain, e | 80.79 |
| >4fbr_A Lectin, myxobacterial hemagglutinin; beta-barrel, HIV-inactivating, carbohydrate binding protein; 1.60A {Myxococcus xanthus} PDB: 4fbv_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=7e-23 Score=209.93 Aligned_cols=235 Identities=11% Similarity=-0.047 Sum_probs=166.0
Q ss_pred ccccceeeccCCCC---ccCCCCCCCCCCCCCCCCCCCCcCCCCCCCCcccC--CCceeeCCCCCCCCCCCCCCCCCccC
Q psy6207 461 SLTLFTFLSLTHSG---FSGRHCEKPCPQGSYGQDCSQTCLCSKEGSASCSP--GSGQCVCRPGGAGQLCDRPCSEGRYG 535 (823)
Q Consensus 461 ~~~~~s~~C~C~~G---y~G~~C~~~C~~g~~g~~C~~~c~C~~~g~g~C~~--~~~~C~C~~G~~G~~C~~~c~~g~~~ 535 (823)
.+..++|++.+.+| |+|.+++.. ++++.. +|.+ +|+|++ .+|+|.|++||+|.+|+.. +
T Consensus 7 ~n~~Gg~s~~~~pgg~~~~g~~~~~n------~~~~~~--~c~n--gG~C~~g~~~y~C~Cp~Gf~G~~Ce~n------i 70 (267)
T 4fbr_A 7 QNQWGGSQATWNPGGLWLIGARDKQN------VVALDI--KSDD--GGKTLKGTMTYNGEGPIGFRGTLSSAN------N 70 (267)
T ss_dssp EEECSSTTSCCEEEEEEECCCCSSCC------EEEEEE--ECSS--TTSEEEEEEEETTSCCEEEEEEECSTT------E
T ss_pred eecCCcccCCcCCCCceeeccccccc------cccCCC--CcCC--CCeecCCCCCeEEeCCCCccccccccc------c
Confidence 44566888899988 678877764 222222 5888 999987 4899999999999999986 5
Q ss_pred CC------CCCCCCCCCCCeeeCCCcEEeCCCCCcCCCccccCcCCcCCCCCCCCCCCCCCCCCeeec--CCCeEecCCC
Q psy6207 536 QN------CTQECRCMNGAACNPQDGTCLCPAGYYGPLCQKRCEFMTYGRNCAQACTCFTENSQGCDI--VTGKCICRPG 607 (823)
Q Consensus 536 ~~------C~~~c~C~~~g~C~~~~~~C~C~~G~~G~~C~~~c~~~~~g~~C~~~~~C~~~~~~~C~~--~~~~C~C~~G 607 (823)
++ |.+. ||+++++| |+|..|++. ++|+.. +| .++++|++ .+|+|+|++|
T Consensus 71 ~ec~~~~~c~s~-pC~nggtc------------~~G~~c~~~-------~eC~s~-pC--~ngG~C~~~~~sy~C~C~~G 127 (267)
T 4fbr_A 71 YTVENQWGGTSA-PWQPGGVW------------VLGARDKQN-------IVAVSI-KS--NDGGKTLTGTTTYNGEGPIG 127 (267)
T ss_dssp EEEEEESSSTTS-CEEEEEEE------------ECCCCSSCC-------EEEEEE-EC--SSTTSEEEEEEEETTSCCEE
T ss_pred cccccccCcCCC-cccCCCee------------eccCccccc-------cccCCC-CC--CCCCEEecCCccEEeeCCCC
Confidence 66 5555 77777665 467888764 346654 78 89999975 5899999999
Q ss_pred CCCCCccccCCCCCccCCCCCCC-----CCCCCCCeecCCCCeeecCCCCCCCCCCCCCCCCCcCCcccccccccCCCCC
Q psy6207 608 FKGHRCETQCSNPNTYGEDCSLD-----CGCNNGGTCNQLDGGCNCGRGYQGKLCTAPCPEGQYGYNCKEECLTKGQDVP 682 (823)
Q Consensus 608 ~~G~~C~~~c~~~~~~~~~C~~~-----~~C~~~g~C~~~~~~C~C~~Gy~G~~C~~~c~~g~~g~~C~~~c~c~~~~~~ 682 (823)
|+|..|+.. +++|+.. .+|.++++| |.|.+|++.. +
T Consensus 128 f~G~~Ce~~-------~d~C~n~~~c~s~pC~ngg~c------------~~G~~c~~~i-------~------------- 168 (267)
T 4fbr_A 128 FKSEVTDGD-------TYSVENQWGGSAAPWHSGGVW------------VLGTRGKQNV-------I------------- 168 (267)
T ss_dssp EEEEECCCC-------EEEEEEECSSTTSCCEEEEEE------------ECCSSTTSCE-------E-------------
T ss_pred ccccCCCCC-------cccccccCCcCCccccCCcce------------eccccccccc-------c-------------
Confidence 999999876 4564433 145544444 4566666531 1
Q ss_pred cccccccccccccccCceeeeeeeeceeeecccceeEeecccceeeecCCeeecccCccCCCCCCCCCCCCCC---CCCC
Q psy6207 683 VRTAVSHALKVHMGINARRYVNVRMVATFNTTLYLYLFVNLTYGILYKTLVRLRECEERCPPGTHGPSCINRC---RCQN 759 (823)
Q Consensus 683 ~~~~~~~~~~~~c~~~g~~~~~~~~~~~C~~~~g~~~~~~~~~~C~C~~G~~g~~C~~~C~~g~~G~~C~~~C---~C~~ 759 (823)
+...+|.++| +|++...+|+ |+|++||+|.+|+.. ++++ ..-.
T Consensus 169 -------c~~~~c~ngg----------~C~dg~~~y~-------C~Cp~Gf~G~~c~~~----------i~ec~~~~~c~ 214 (267)
T 4fbr_A 169 -------NVDAKSNDGG----------KTLSGTMTYN-------GEGPIGFRGTLTSPD----------TYTVENQWGGS 214 (267)
T ss_dssp -------EEEEECSSTT----------SEEEEEEEET-------TSCCEEEEEEEEETT----------EEEEEEECSCT
T ss_pred -------cCCCCCCCCC----------EeeCCCCCeE-------EeCCCCccccccccc----------cceeccCCCcc
Confidence 2245678999 9999888888 999999999999875 2222 1122
Q ss_pred CCeecCC-CCeeeCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCeeecc--CceeecCCCCccC
Q psy6207 760 GAICNPA-NGQCLCAPGWMGSVCNVPCTPGMWGQGCTVPCECFNGASCHHV--TGECQCEPGFKGQ 822 (823)
Q Consensus 760 ~g~C~~~-~~~C~C~~G~~G~~C~~~C~~~~~g~~C~~~c~C~~~~~C~~~--~g~C~C~~G~~G~ 822 (823)
.+.|.+. .+.+.|+.++.+..|+. +|.|+|+|++. .++|.||+||+|.
T Consensus 215 ~~~c~~gG~~~~~C~~g~n~~~c~~---------------~c~ngGtC~dg~~sy~CeCp~GF~G~ 265 (267)
T 4fbr_A 215 TAPWNPGGFWMIGARNGQNVVALNV---------------ASSDGGKTLAGTMIYNGEGPIGFRAR 265 (267)
T ss_dssp TSCCEEEEEEECCCCTTCCEEEEEE---------------ECSSTTSEEEEEEEETTSCCEEEEEE
T ss_pred CCcccCCCeEEEecCCCCccccCCc---------------CCCCCCEeeCCCcceeecCCCCcccc
Confidence 2233332 23455777777655433 67899999975 3599999999985
|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} | Back alignment and structure |
|---|
| >4fbr_A Lectin, myxobacterial hemagglutinin; beta-barrel, HIV-inactivating, carbohydrate binding protein; 1.60A {Myxococcus xanthus} PDB: 4fbv_A* | Back alignment and structure |
|---|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* | Back alignment and structure |
|---|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} | Back alignment and structure |
|---|
| >2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A | Back alignment and structure |
|---|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* | Back alignment and structure |
|---|
| >2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A | Back alignment and structure |
|---|
| >3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 4g1e_B* 3ije_B* 4g1m_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* | Back alignment and structure |
|---|
| >1klo_A Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: g.3.11.2 g.3.11.2 g.3.11.2 PDB: 1npe_B 1tle_A | Back alignment and structure |
|---|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* | Back alignment and structure |
|---|
| >3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 4g1e_B* 3ije_B* 4g1m_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* | Back alignment and structure |
|---|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* | Back alignment and structure |
|---|
| >4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} | Back alignment and structure |
|---|
| >1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A | Back alignment and structure |
|---|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
| >1klo_A Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: g.3.11.2 g.3.11.2 g.3.11.2 PDB: 1npe_B 1tle_A | Back alignment and structure |
|---|
| >1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A | Back alignment and structure |
|---|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
| >4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} | Back alignment and structure |
|---|
| >3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* | Back alignment and structure |
|---|
| >3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* | Back alignment and structure |
|---|
| >2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A | Back alignment and structure |
|---|
| >2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A | Back alignment and structure |
|---|
| >1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A | Back alignment and structure |
|---|
| >1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A | Back alignment and structure |
|---|
| >1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* | Back alignment and structure |
|---|
| >1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A | Back alignment and structure |
|---|
| >1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* | Back alignment and structure |
|---|
| >1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A | Back alignment and structure |
|---|
| >1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A | Back alignment and structure |
|---|
| >1n7d_A LDL receptor, low-density lipoprotein receptor; familial hypercholesterolemia, cholestero metabolism, lipid transport; HET: NAG BMA MAN KEG; 3.70A {Homo sapiens} SCOP: b.68.5.1 g.3.11.1 g.3.11.1 g.3.11.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 PDB: 2lgp_A 1xfe_A 1f5y_A 1ldl_A 1ldr_A 1d2j_A 1f8z_A | Back alignment and structure |
|---|
| >2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
| >1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A | Back alignment and structure |
|---|
| >2p28_B Integrin beta-2; hybrid domain, PSI domain, I-EGF DOM cell adhesion; HET: NAG; 2.20A {Homo sapiens} PDB: 1l3y_A | Back alignment and structure |
|---|
| >1n7d_A LDL receptor, low-density lipoprotein receptor; familial hypercholesterolemia, cholestero metabolism, lipid transport; HET: NAG BMA MAN KEG; 3.70A {Homo sapiens} SCOP: b.68.5.1 g.3.11.1 g.3.11.1 g.3.11.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 PDB: 2lgp_A 1xfe_A 1f5y_A 1ldl_A 1ldr_A 1d2j_A 1f8z_A | Back alignment and structure |
|---|
| >2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
| >2p28_B Integrin beta-2; hybrid domain, PSI domain, I-EGF DOM cell adhesion; HET: NAG; 2.20A {Homo sapiens} PDB: 1l3y_A | Back alignment and structure |
|---|
| >1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* | Back alignment and structure |
|---|
| >1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* | Back alignment and structure |
|---|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A | Back alignment and structure |
|---|
| >3zyj_B Netrin-G1; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A | Back alignment and structure |
|---|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* | Back alignment and structure |
|---|
| >3zyj_B Netrin-G1; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
| >2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... | Back alignment and structure |
|---|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* | Back alignment and structure |
|---|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* | Back alignment and structure |
|---|
| >2wg3_C Hedgehog-interacting protein; lipoprotein, development, membrane, secreted, protease, PALM hydrolase, developmental protein, autocatalytic cleavage; HET: NAG; 2.60A {Homo sapiens} PDB: 2wg4_B 2wfx_B 2wft_A 3ho3_A 3ho4_A 3ho5_A | Back alignment and structure |
|---|
| >2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... | Back alignment and structure |
|---|
| >3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens} | Back alignment and structure |
|---|
| >2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... | Back alignment and structure |
|---|
| >3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens} | Back alignment and structure |
|---|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 | Back alignment and structure |
|---|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* | Back alignment and structure |
|---|
| >3m0c_C LDL receptor, low-density lipoprotein receptor; protein complex, beta propeller, cholesterol clearance, PCSK autocatalytic cleavage; 7.01A {Homo sapiens} | Back alignment and structure |
|---|
| >3m0c_C LDL receptor, low-density lipoprotein receptor; protein complex, beta propeller, cholesterol clearance, PCSK autocatalytic cleavage; 7.01A {Homo sapiens} | Back alignment and structure |
|---|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A | Back alignment and structure |
|---|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 | Back alignment and structure |
|---|
| >3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} | Back alignment and structure |
|---|
| >2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... | Back alignment and structure |
|---|
| >2wg3_C Hedgehog-interacting protein; lipoprotein, development, membrane, secreted, protease, PALM hydrolase, developmental protein, autocatalytic cleavage; HET: NAG; 2.60A {Homo sapiens} PDB: 2wg4_B 2wfx_B 2wft_A 3ho3_A 3ho4_A 3ho5_A | Back alignment and structure |
|---|
| >2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A | Back alignment and structure |
|---|
| >2y38_A Laminin subunit alpha-5; structural protein, cell adhesion, basement membrane; HET: NAG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
| >3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} | Back alignment and structure |
|---|
| >2y38_A Laminin subunit alpha-5; structural protein, cell adhesion, basement membrane; HET: NAG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
| >4aqt_A Laminin subunit gamma-1; cell adhesion; HET: NAG BMA; 3.20A {Mus musculus} | Back alignment and structure |
|---|
| >4aqt_A Laminin subunit gamma-1; cell adhesion; HET: NAG BMA; 3.20A {Mus musculus} | Back alignment and structure |
|---|
| >3ca7_A Protein spitz; argos, EGF, developmental protein, differentiation, EGF-like domain, endoplasmic reticulum, glycoprotein, golgi apparatus; 1.50A {Drosophila melanogaster} PDB: 3c9a_C 3ltg_D | Back alignment and structure |
|---|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
| >1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A | Back alignment and structure |
|---|
| >1hae_A Heregulin-alpha; growth factor; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1haf_A 1hre_A 1hrf_A | Back alignment and structure |
|---|
| >3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L | Back alignment and structure |
|---|
| >1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A | Back alignment and structure |
|---|
| >2k2s_B Micronemal protein 6; microneme protein complex, cell adhesion, cytoplasmic vesicl lectin, virulence, EGF-like domain, membrane; NMR {Toxoplasma gondii} PDB: 2k2t_A | Back alignment and structure |
|---|
| >3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L | Back alignment and structure |
|---|
| >2k2s_B Micronemal protein 6; microneme protein complex, cell adhesion, cytoplasmic vesicl lectin, virulence, EGF-like domain, membrane; NMR {Toxoplasma gondii} PDB: 2k2t_A | Back alignment and structure |
|---|
| >1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A | Back alignment and structure |
|---|
| >1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A | Back alignment and structure |
|---|
| >3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus} | Back alignment and structure |
|---|
| >1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C* | Back alignment and structure |
|---|
| >1hae_A Heregulin-alpha; growth factor; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1haf_A 1hre_A 1hrf_A | Back alignment and structure |
|---|
| >1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C* | Back alignment and structure |
|---|
| >2fd6_A Urokinase-type plasminogen activator; UPAR, ATF, ATN-615 antibody, FAB, ternary complex, immune SY hydrolase; HET: PGE NAG FUC NDG PG4; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 3bt2_A* 3bt1_A* 3u73_A* 1urk_A* 3laq_A* 1kdu_A | Back alignment and structure |
|---|
| >3ltf_D Protein spitz; receptor-ligand complex ectodomain cysteine rich domain EGF ATP-binding, kinase, nucleotide-binding, receptor; HET: NAG MAN; 3.20A {Drosophila melanogaster} | Back alignment and structure |
|---|
| >3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus} | Back alignment and structure |
|---|
| >3ca7_A Protein spitz; argos, EGF, developmental protein, differentiation, EGF-like domain, endoplasmic reticulum, glycoprotein, golgi apparatus; 1.50A {Drosophila melanogaster} PDB: 3c9a_C 3ltg_D | Back alignment and structure |
|---|
| >3ltf_D Protein spitz; receptor-ligand complex ectodomain cysteine rich domain EGF ATP-binding, kinase, nucleotide-binding, receptor; HET: NAG MAN; 3.20A {Drosophila melanogaster} | Back alignment and structure |
|---|
| >2fd6_A Urokinase-type plasminogen activator; UPAR, ATF, ATN-615 antibody, FAB, ternary complex, immune SY hydrolase; HET: PGE NAG FUC NDG PG4; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 3bt2_A* 3bt1_A* 3u73_A* 1urk_A* 3laq_A* 1kdu_A | Back alignment and structure |
|---|
| >2ygo_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: MLY PCF NAG; 1.85A {Homo sapiens} PDB: 2ygp_A* | Back alignment and structure |
|---|
| >3e50_C Protransforming growth factor alpha; IDE, TGF-alpha, cytoplasm, hydrolase, metal-binding, metalloprotease, polymorphism, protease, zinc; 2.30A {Homo sapiens} SCOP: g.3.11.1 PDB: 1yuf_A 1yug_A 2tgf_A 1mox_C 3tgf_A 4tgf_A | Back alignment and structure |
|---|
| >2rnl_A Amphiregulin; AR, colorectum cell-derived growth factor, EGF-like domain, CRDGF, cytokine, glycoprotein, membrane, polymorphism, transmembrane; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A | Back alignment and structure |
|---|
| >2ygo_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: MLY PCF NAG; 1.85A {Homo sapiens} PDB: 2ygp_A* | Back alignment and structure |
|---|
| >1xdt_R Hbegf, heparin-binding epidermal growth factor; complex (toxin-growth factor), diphtheria toxin, receptor, H binding epidermal growth factor; 2.65A {Homo sapiens} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >2i9a_A Urokinase-type plasminogen activator; growth factor-like domain, kringle domain, hydrolase; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 2i9b_A* | Back alignment and structure |
|---|
| >2rnl_A Amphiregulin; AR, colorectum cell-derived growth factor, EGF-like domain, CRDGF, cytokine, glycoprotein, membrane, polymorphism, transmembrane; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >1iox_A Betacellulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1ip0_A | Back alignment and structure |
|---|
| >3e50_C Protransforming growth factor alpha; IDE, TGF-alpha, cytoplasm, hydrolase, metal-binding, metalloprotease, polymorphism, protease, zinc; 2.30A {Homo sapiens} SCOP: g.3.11.1 PDB: 1yuf_A 1yug_A 2tgf_A 1mox_C 3tgf_A 4tgf_A | Back alignment and structure |
|---|
| >1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A | Back alignment and structure |
|---|
| >2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ... | Back alignment and structure |
|---|
| >2i9a_A Urokinase-type plasminogen activator; growth factor-like domain, kringle domain, hydrolase; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 2i9b_A* | Back alignment and structure |
|---|
| >3nt1_A Prostaglandin-endoperoxide synthase 2; prostaglandin H2 synthase, cyclooxygenase-2, naproxen, oxido; HET: NAG BOG NPS HEM; 1.73A {Mus musculus} PDB: 3ln1_A* 3mqe_A* 3ln0_A* 3ntb_A* 3q7d_A* 4fm5_A* 1pxx_A* 3pgh_A* 1cx2_A* 4cox_A* 5cox_A* 6cox_A* 3qh0_A* 3qmo_A* 4e1g_A* 3olu_A* 3olt_A* 3hs5_A* 3hs6_A* 3hs7_A* ... | Back alignment and structure |
|---|
| >1q4g_A Prostaglandin G/H synthase 1; cyclooxygenase, non-steroidal anti-inflammatory drug, peroxi prostaglandin synthase, EGF-like domain; HET: BOG NAG NDG BMA MAN BFL HEM; 2.00A {Ovis aries} SCOP: a.93.1.2 g.3.11.1 PDB: 1diy_A* 2ayl_A* 3kk6_A* 3n8v_A* 3n8w_A* 3n8x_A* 3n8y_A* 3n8z_A* 2oyu_P* 2oye_P* 1eqg_A* 1cqe_A* 1eqh_A* 1igz_A* 1igx_A* 1fe2_A* 1pge_A* 1pgf_A* 1pgg_A* 3n8w_B* ... | Back alignment and structure |
|---|
| >1xdt_R Hbegf, heparin-binding epidermal growth factor; complex (toxin-growth factor), diphtheria toxin, receptor, H binding epidermal growth factor; 2.65A {Homo sapiens} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >3nt1_A Prostaglandin-endoperoxide synthase 2; prostaglandin H2 synthase, cyclooxygenase-2, naproxen, oxido; HET: NAG BOG NPS HEM; 1.73A {Mus musculus} PDB: 3ln1_A* 3mqe_A* 3ln0_A* 3ntb_A* 3q7d_A* 4fm5_A* 1pxx_A* 3pgh_A* 1cx2_A* 4cox_A* 5cox_A* 6cox_A* 3qh0_A* 3qmo_A* 4e1g_A* 3olu_A* 3olt_A* 3hs5_A* 3hs6_A* 3hs7_A* ... | Back alignment and structure |
|---|
| >1kig_L Factor XA; glycoprotein, serine protease, plasma, blood coagulation, complex (protease/inhibitor); 3.00A {Bos taurus} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >2bz6_L Blood coagulation factor VIIA; serine protease, enzyme complex, hydrolase; HET: 346; 1.6A {Homo sapiens} SCOP: g.3.11.1 PDB: 1w8b_L* 1w7x_L* 1cvw_L* | Back alignment and structure |
|---|
| >2p26_A Integrin beta-2; hybrid domain, PSI domain, I-EGF DOM cell adhesion; HET: NAG; 1.75A {Homo sapiens} PDB: 1yuk_B* 1yuk_A* 2p28_A* | Back alignment and structure |
|---|
| >2p26_A Integrin beta-2; hybrid domain, PSI domain, I-EGF DOM cell adhesion; HET: NAG; 1.75A {Homo sapiens} PDB: 1yuk_B* 1yuk_A* 2p28_A* | Back alignment and structure |
|---|
| >1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A | Back alignment and structure |
|---|
| >1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A | Back alignment and structure |
|---|
| >1n1i_A Merozoite surface protein-1; MSP1, malaria, surface antigen, glycoprotein, EGF domain, cell adhesion; HET: HIS; 2.40A {Plasmodium knowlesi strain H} SCOP: g.3.11.4 g.3.11.4 | Back alignment and structure |
|---|
| >2e26_A Reelin, reeler protein; signaling protein; HET: NAG BMA; 2.00A {Mus musculus} PDB: 3a7q_A* | Back alignment and structure |
|---|
| >1n1i_A Merozoite surface protein-1; MSP1, malaria, surface antigen, glycoprotein, EGF domain, cell adhesion; HET: HIS; 2.40A {Plasmodium knowlesi strain H} SCOP: g.3.11.4 g.3.11.4 | Back alignment and structure |
|---|
| >1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >1iox_A Betacellulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1ip0_A | Back alignment and structure |
|---|
| >2e26_A Reelin, reeler protein; signaling protein; HET: NAG BMA; 2.00A {Mus musculus} PDB: 3a7q_A* | Back alignment and structure |
|---|
| >2kl7_A Fibulin-4; secreted, calcium, disease mutation, disulfide bond, EGF- like domain, glycoprotein, polymorphism, structural genomics, PSI-2; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A | Back alignment and structure |
|---|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
No hit with e-value below 0.005
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 823 | |||
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 98.11 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 98.08 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 98.03 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 97.99 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 97.95 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 97.93 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 97.92 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 97.91 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 97.86 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 97.69 | |
| d1tpga1 | 41 | Plasminogen activator (tissue-type), t-PA {Human ( | 97.6 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 97.59 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 97.57 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 97.56 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 97.56 | |
| d1g1sa2 | 40 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 97.5 | |
| d1tpga1 | 41 | Plasminogen activator (tissue-type), t-PA {Human ( | 97.45 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 97.42 | |
| d1q4ga2 | 42 | Prostaglandin H2 synthase-1, EGF-like module {Shee | 97.35 | |
| d1g1sa2 | 40 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 97.29 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 97.26 | |
| d1cvua2 | 41 | Prostaglandin H2 synthase-1, EGF-like module {Mous | 97.25 | |
| d1cvua2 | 41 | Prostaglandin H2 synthase-1, EGF-like module {Mous | 97.2 | |
| d1q4ga2 | 42 | Prostaglandin H2 synthase-1, EGF-like module {Shee | 96.68 | |
| d3egfa_ | 53 | Epidermal growth factor, EGF {Mouse (Mus musculus) | 96.44 | |
| d3egfa_ | 53 | Epidermal growth factor, EGF {Mouse (Mus musculus) | 96.34 | |
| d1haea_ | 63 | Heregulin-alpha, EGF-like domain {Human (Homo sapi | 96.32 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 96.0 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 95.92 | |
| d1nqlb_ | 48 | Epidermal growth factor, EGF {Human (Homo sapiens) | 95.91 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 95.71 | |
| d2i9aa1 | 40 | Plasminogen activator (urokinase-type) {Human (Hom | 95.67 | |
| d2i9aa1 | 40 | Plasminogen activator (urokinase-type) {Human (Hom | 95.61 | |
| d1haea_ | 63 | Heregulin-alpha, EGF-like domain {Human (Homo sapi | 95.46 | |
| d1kloa3 | 51 | Laminin gamma1 chain {Mouse (Mus musculus) [TaxId: | 95.44 | |
| d1kloa1 | 55 | Laminin gamma1 chain {Mouse (Mus musculus) [TaxId: | 95.35 | |
| d1kloa2 | 56 | Laminin gamma1 chain {Mouse (Mus musculus) [TaxId: | 95.31 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 95.23 | |
| d1nqlb_ | 48 | Epidermal growth factor, EGF {Human (Homo sapiens) | 95.22 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 94.4 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 94.39 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 94.29 | |
| d1k36a_ | 46 | Epiregulin, EGF-domain {Human (Homo sapiens) [TaxI | 94.0 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 93.64 | |
| d1kloa1 | 55 | Laminin gamma1 chain {Mouse (Mus musculus) [TaxId: | 93.56 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 93.47 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 93.43 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 93.35 | |
| d1kloa3 | 51 | Laminin gamma1 chain {Mouse (Mus musculus) [TaxId: | 93.1 | |
| d1l3ya_ | 41 | Integrin beta EGF-like domains {Human (Homo sapien | 92.85 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 92.85 | |
| d1kloa2 | 56 | Laminin gamma1 chain {Mouse (Mus musculus) [TaxId: | 92.52 | |
| d1k36a_ | 46 | Epiregulin, EGF-domain {Human (Homo sapiens) [TaxI | 92.46 | |
| d1apqa_ | 53 | Complement protease C1R {Human (Homo sapiens) [Tax | 92.21 | |
| d1ioxa_ | 50 | Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606] | 92.07 | |
| d1xdtr_ | 41 | Heparin-binding epidermal growth factor, HBEGF {Hu | 91.71 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 91.42 | |
| d1dx5i3 | 40 | Thrombomodulin, different EGF-like domains {Human | 91.24 | |
| d1dx5i3 | 40 | Thrombomodulin, different EGF-like domains {Human | 90.62 | |
| d1moxc_ | 49 | Transforming growth factor alpha {Human (Homo sapi | 90.21 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 89.96 | |
| d1jv2b4 | 31 | Integrin beta EGF-like domains {Human (Homo sapien | 89.74 | |
| d1jv2b4 | 31 | Integrin beta EGF-like domains {Human (Homo sapien | 89.73 | |
| d1l3ya_ | 41 | Integrin beta EGF-like domains {Human (Homo sapien | 89.31 | |
| d1xdtr_ | 41 | Heparin-binding epidermal growth factor, HBEGF {Hu | 88.85 | |
| d1szba2 | 45 | Mannose-binding protein associated serine protease | 87.81 | |
| d1nt0a3 | 45 | Mannose-binding protein associated serine protease | 87.18 | |
| d1apqa_ | 53 | Complement protease C1R {Human (Homo sapiens) [Tax | 86.93 | |
| d1ioxa_ | 50 | Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606] | 86.92 | |
| d1szba2 | 45 | Mannose-binding protein associated serine protease | 86.38 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 86.37 | |
| d1moxc_ | 49 | Transforming growth factor alpha {Human (Homo sapi | 85.9 | |
| d1nt0a3 | 45 | Mannose-binding protein associated serine protease | 85.85 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 85.2 | |
| d1nzia2 | 42 | Complement C1S component {Human (Homo sapiens) [Ta | 84.72 | |
| d1jv2b5 | 43 | Integrin beta EGF-like domains {Human (Homo sapien | 83.25 | |
| d3bpse1 | 40 | Low density lipoprotein (LDL) receptor, different | 80.7 |
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.11 E-value=8.4e-07 Score=61.06 Aligned_cols=35 Identities=34% Similarity=0.811 Sum_probs=31.6
Q ss_pred CCCCCCCCCCCCCCeeeCC--CcEEeCCCCCcCCCccc
Q psy6207 535 GQNCTQECRCMNGAACNPQ--DGTCLCPAGYYGPLCQK 570 (823)
Q Consensus 535 ~~~C~~~c~C~~~g~C~~~--~~~C~C~~G~~G~~C~~ 570 (823)
+|+|+++ ||+++|+|++. +|+|.|++||+|.+||.
T Consensus 1 Id~C~~~-PC~n~g~C~~~~~~y~C~C~~G~~G~~Ce~ 37 (39)
T d2vj3a2 1 VNECVSN-PCQNDATCLDQIGEFQCICMPGYEGVHCEV 37 (39)
T ss_dssp CCTTTTC-CCCSSCEEEECSSCEEEECCTTEESSSSCE
T ss_pred CcCCcCC-CCCCCCEEECCCCCEEEeCCCCCccCcCee
Confidence 4789888 99999999986 67999999999999985
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
| >d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]} | Back information, alignment and structure |
|---|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]} | Back information, alignment and structure |
|---|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2i9aa1 g.3.11.1 (A:10-49) Plasminogen activator (urokinase-type) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2i9aa1 g.3.11.1 (A:10-49) Plasminogen activator (urokinase-type) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1kloa3 g.3.11.2 (A:122-172) Laminin gamma1 chain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1kloa1 g.3.11.2 (A:11-65) Laminin gamma1 chain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1kloa2 g.3.11.2 (A:66-121) Laminin gamma1 chain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1k36a_ g.3.11.1 (A:) Epiregulin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1kloa1 g.3.11.2 (A:11-65) Laminin gamma1 chain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1kloa3 g.3.11.2 (A:122-172) Laminin gamma1 chain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1l3ya_ g.3.11.6 (A:) Integrin beta EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1kloa2 g.3.11.2 (A:66-121) Laminin gamma1 chain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1k36a_ g.3.11.1 (A:) Epiregulin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1ioxa_ g.3.11.1 (A:) Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1xdtr_ g.3.11.1 (R:) Heparin-binding epidermal growth factor, HBEGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1moxc_ g.3.11.1 (C:) Transforming growth factor alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1jv2b4 g.3.11.6 (B:532-562) Integrin beta EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1jv2b4 g.3.11.6 (B:532-562) Integrin beta EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1l3ya_ g.3.11.6 (A:) Integrin beta EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1xdtr_ g.3.11.1 (R:) Heparin-binding epidermal growth factor, HBEGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1ioxa_ g.3.11.1 (A:) Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1moxc_ g.3.11.1 (C:) Transforming growth factor alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1nzia2 g.3.11.1 (A:118-159) Complement C1S component {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1jv2b5 g.3.11.6 (B:563-605) Integrin beta EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|